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ABSTRACT 
Buffalopox (BPX) is a zoonotic infection affecting humans, cattle and buffalo. Though, the 
infection is not associated with heavy mortality even then it badly affects the working 
capacity and productivity of the animals ensuing huge losses in terms of economy. Disease 
has been recorded from various parts of the world. A number of sporadic out breaks of BPX 
have also been recorded in Pakistan and their number is increasing every year. This project 
was planned to study the pathological and hematological changes, association of different 
factors in BPX production and preparation of vaccine. During the study, blood samples 
(n=163) and scab samples (n=19) from BPX suspected buffaloes, and blood samples (n=21) 
from healthy buffaloes were collected from a total of 96 herds having 975 buffaloes. Blood 
samples were used to count red blood cells (RBCs), hemoglobin concentration (Hb conc.), 
packed cell volume (PCV), total leukocyte counts (TLCs) and differential leukocyte counts 
(DLCs) in apparently healthy and diseased animals. In hematological studies, non-significant 
(P > 0.05) difference was observed on RBC count, Hb conc., PCV and PLT in BPX virus 
(BPXV) infected and healthy animals of all age groups i.e. 2-4 years, 5-7 years and 8-10 
years. Significant (P < 0.05) increase was observed on TLC in BPXV infected buffaloes of 
all the groups and this increase was due to increase in number of lymphocytes. Frequency 
analysis and 95% confidence limits showed that, significant effect (P < 0.05) of following 
factors was observed in pox production: milker’s fever, milker’s skin lesions, presence of 
multiple species in the same herd, introduction of young buffaloes, total no. of animals, 
reluctance of animals during milking, milk yield and septic condition of animals with 
different percentages of pox positive animals. However, non-significant effect (P > 0.05) of 
following factors was observed on disease production; multiple person milking, type of 
housing, age of the animal and type of herd. Multivariate logistic regression analysis revealed 
that introduction of young buffaloes, total no. of animals, animals reluctant in milking, 
decreased milk production, septic condition in animals, milking from multiple persons, 
housing, area of sampling, age of animal and type of herd (dairy/mix) were backward 
eliminated factors. It was found that three factors were significantly (P < 0.05) associated 
with disease progression i.e. skin lesions in milkers, fever in milkers and presence of other 
animal species in the same herd. Log odd ratios showed that there were 6-times, 5-times and 
3-times more chance of occurrence of pox disease in herds where milkers having skin 
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lesions, milkers suffering from fever and animals other than buffaloes were also reared in the 
same herd, respectively. Scab samples were subjected to polymerase chain reaction (PCR) 
for identification of BPXV by amplification of C18L gene, and a band size of 138bp was 
obtained with primer set of BPXV-C18L-F/BPXV-C18L-R from BPXV positive samples. 
Out of nineteen scab samples, fifteen samples were positive for BPX on the basis of PCR. 
Further, 78.94% scabs producing lesions were due to BPXV. Positive scab sample on the 
basis of PCR was subsequently used for attenuation of virus on Vero cells by serial passages 
to prepare vaccine. Attenuation status of the virus was assessed in rabbits at different passage 
levels by inoculation of wet material intradermally to determine its degree of infectivity. In 
histological sections of lesions from BPXV infected animals, marked hyperkeratosis in 
epidermis, mononuclear cell infiltration in connective tissue of dermis and vacuolar 
degeneration of keratinocytes were observed. Ballooning degeneration with large 
intracytoplasmic, eosinophilic inclusion bodies were characteristic features in keratinocytes 
of BPXV infected rabbits. Trials were conducted in rabbits to check the efficacy of vaccine. 
Preventable fraction of Vero cell adopted BPXV of 51st passage was 100% and 66.67% at 
100 TCID50 and at 1000 TCID50, respectively, and it can be used safely for vaccine 
preparation against BPXV in animals. 
 
 
 
CHAPTER 1 
INTRODUCTION 
 A variety of viral diseases have been recorded to be re-emerging. Many of them pose 
a risk to community health, veterinarians and other public in contact with domesticated 
animals including cows and buffaloes, and buffalopox (BPX) infection is one of them. 
Buffalopox is a contagious, infectious viral disease of zoonotic importance that affects 
humans, cattle and buffaloes (Bubalus bubalis) (Bhanuprakash et al., 2010). Etiologic agent 
belongs to the genus Orthopoxvirus (OPXV) in the family Poxviridae (Matthews, 1982). 
Viruses of Poxviridae family have complex and large virion with a size of 140-260 nm x 
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220-450 nm that can be seen by light microscope. These viruses are enveloped and brick 
shaped. The genome is ds DNA molecule of 130-375 kbp, size varying between different 
genera and strains. Central part of the genome (approximately 100 kbp) is highly conserved 
in content, sequences and gene order, while terminal regions vary in patterns of restriction 
enzyme cleavage sites and length (Esposito and Knight, 1985). 
 Buffalopox was declared as one of the important zoonotic infections by the Joint 
Expert Committee on Zoonosis. This committee emphasized that transmission mode of BPX 
to humans and epidemiological factors, seems to be analogous to that of cowpox (CPX) 
(Chandra et al., 1987). Phylogenetic analysis of structural protein genes (Singh et al., 2006a; 
Singh et al., 2007) and non-structural protein genes revealed that across the genus, these 
viruses are conserved, and further, that BPX virus (BPXV) is strongly related to vaccinal 
strains of vaccinia virus (VACV) (Dumbell and Richardson, 1993; Singh et al., 2006b). 
Incubation period of BPX in humans is comparatively longer i.e. 3-19 days whereas it is 2-4 
days in animals (Ghosh et al., 1977). Full course of the disease is 3 to 4 weeks. Lesions in 
animals are generally localized on the teats, medial aspects of thighs and in some cases 
quarters, lips, eyes and nostrils. In few cases, the lesions are found on ear flaps and around 
eyes without involving udder and teats or other parts of the body in buffaloes (Sharma, 
1934). Calves that suckle affected cows also develop lesions on muzzle, lips and mouth 
(Trindade et al., 2008). Though, the infection is not associated with heavy mortality even 
then it adversely affects the working capacity and productivity of the animals ensuing huge 
losses to the economy. In most cases, mastitis is recorded as a secondary problem 
(Muhammad et al., 1998). As BPX is a contagious disease, its morbidity has been reported 
up to 80% in affected herds causing high economic losses to the farmers mainly due to 
secondary complications (Singh et al., 2006a). Due to mastitis in pox affected animals, 40-
70% reduction in milk production has been observed, therefore having an impact on dairy 
industry (Essbauer et al., 2010). In India, a very high prevalence (23.4-79.4%) of BPX has 
been observed (Muraleedharan et al., 1989), however, data from only one district of Pakistan 
showed that here its prevalence is 50% (Khan, 2010). Outbreaks of this disease in buffaloes 
occurred in epidemic as well as sporadic forms in commercial and domestic settings in India 
(Chandra et al., 1986a; Raut et al., 1997). Coincident infections have been reported in 
humans, buffaloes and cows (Ghosh et al., 1977; Lal and Singh, 1977). Humans including 
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smallpox-vaccinates got infected on close contact with BPXV infected animals, however the 
degree of disease severity is greater in individuals who are non-immunized (Singh et al., 
2007). Cross-precipitation and cross-neutralization tests prove close association between 
VACV and BPXV (Singh and Singh, 1967; Kataria and Singh, 1970; Baxby and Hill, 1971; 
Lal and Singh, 1973). Nosocomial BPXV infections have also been recorded in paramedical 
staff and patients in a hospital of Karachi, Pakistan (Zafar et al., 2007). Febrile illness, rash, 
pox lesions, malaise, fever, axillary and inguinal lymphadenopathy, and pain at the site of 
lesions are observed in humans (Gurav et al., 2011).  
Disease has been recorded from various parts of the world including Bangladesh, 
Egypt, India, Indonesia, Italy and Russia (Essbauer et al., 2010). A number of sporadic out 
breaks of BPXV in buffaloes have also been recorded in Pakistan (Muhammad et al., 1998; 
Khan, 2010), and in humans (Zafar et al., 2007). Word of mouth information indicates that 
BPX is a disease of economic importance at Landhi cattle colony, Karachi. Now, it is 
spreading rapidly in different areas of Punjab and other provinces, and their number is 
increasing every year (Personal communications). Considering the zoonotic potential and 
productivity losses associated with BPX infection, the significance of control actions in 
minimizing the public health consequences and economic losses cannot be misjudged. 
Furthermore, possible incidence of antibiotic residues in meat and milk of treated animals 
when minimizing secondary complications in BPX-infected animals creates a scenario of 
public health hazard. Buffalopox contaminated meat also has implications in the international 
trade. In the absence of appropriate diagnostic tools and prophylactic strategies, successful 
measures cannot be adopted to manage the infection by BPXV in the various parts of the 
world where VACV and BPXV like agents have been prevalent. Vaccination approach has 
contributed significantly towards controlling and eradicating many human as well as animal 
viral diseases to a greater extent. Very little work has been done on BPXV in Pakistan so far 
and to some extent in other parts of the world. Keeping in view the economic and zoonotic 
importance, there is a need to have a comprehensive research against this disease that will 
help in formulation of preventive strategies ultimately minimizing the economic losses to 
livestock industry. Therefore, the present study was designed to achieve the following goals: 
1. Identification of BPXV by polymerase chain reaction (PCR). 
2. Pathological changes on skin of BPX affected animals. 
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3. Hematological effects in BPX affected buffaloes. 
4. Effect and association of different factors in disease production. 
5. Attenuation of field BPXV on Vero cells by multiple passages for vaccine 
development and then trials in rabbits to check vaccine efficacy.  
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CHAPTER 2 
REVIEW OF LITERATURE 
2.1. Importance of pox viruses 
 The most renowned member of the Poxviridae family, variola virus (VARV), caused 
smallpox, a disease that witnessed killing more humans in history than any other disease 
(Fenner et al., 1988). Although smallpox was eradicated in 1977 through a dedicated effort 
by the World Health Organization (WHO) (Fenner et al., 1988) even though other viruses of 
Poxviridae family cause clinically related diseases in humans and animals. After 1977, 
outbreaks of monkeypox virus (MPXV) emphasized the significance of research on these 
viruses (Reed et al., 2004). In the late sixties of previous century, MPXV was described for 
the very first time as causative agent of pox-like sickness in monkeys. Since that instance the 
understanding on poxviruses was escalating with an unbelievable speed. In the ﬁeld of 
poxvirus research, one more boost became after 9/11 when the world abruptly feared the bio-
terroristic attack using smallpox virus. Efforts were therefore focused on development of 
effective antiviral drugs and safe vaccine (Essbauer et al., 2010). Oncolytic therapies and 
gene-delivery vectors, using poxviruses has also generated curiosity in studying their biology 
(Seet et al., 2003; Thorne, 2011). 
2.2. Etiologic agent 
 Poxviruses are among the longest and well-known viruses to mankind, and they are 
among the most feared viruses to humans and livestock animal. These are large ds DNA 
viruses, replicating exclusively in the cytoplasm of their host cells. Pox viruses can be 
grouped into two-subfamilies: chordopoxvirinae, which infect vertebrates and 
entomopoxvirinae, which infect insects. Among chordopoxvirinae, ten-genera are currently 
recognized: OPXVs, capripoxviruses, parapoxviruses (PPVs), yatapoxviruses, 
leporipoxviruses, cervidpoxviruses, suipoxviruses, molluscipoxviruses, crocodylipoxviruses 
and avipoxviruses (Haller et al., 2014). Members of the Poxviridae family are complex and 
large with a size ranging from 140-260 nm x 220-450 nm i.e. large enough to be seen with 
light microscope. Virion is ds DNA molecule of 130-375 kbp, and size of genome varying 
between different genera and strains. Studies on genetics revealed that central part of the 
genome (approximately 100 kbp) is very much conserved in gene order, sequences and 
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content while terminal regions differ both in patterns and length of restriction enzyme 
cleavage sites (Esposito and Knight, 1985). Only members of the subfamily 
Chordopoxvirinae infect vertebrate hosts with four genera including species that produce 
disease in humans. Three of them are of zoonotic importance i.e. OPXV, Yatapoxvirus. 
However, historically the well-known species of the genus OPXV is VARV that caused 
smallpox; a devastating disease of humans, BPXV has high similarity with this virus and 
VACV, by which small pox has been eradicated (Essbauer et al., 2010). Buffalopox is an 
infectious and contagious viral disease that affects the buffaloes and seldom cows. Morbidity 
in affected herds is up to 80% causing high economic losses to the farmers (Singh at al., 
2006a). The causative agent BPX-virus (BPXV) belongs to genus OPXV, subfamily 
Chordopoxvirinae and in Poxviridae family. Reference strain of BPXV is BP4 strain (Singh 
and Singh, 1967; Baxby and Hill, 1969). 
2.3. History 
 The first reported case of BPX occurred in the year 1934 in Lahore city in the sub-
continent India (Sharma, 1934). After that disease in both severe and mild forms was 
reported from different parts of India. Following the initial report of BPX in 1934 (Sharma, 
1934), the disease is being reported regularly not only in mild but also in severe forms from 
different buffalo-rearing geographical locations (Sehgal et al., 1977; Gurav et al., 2011). 
Outbreaks of pox in buffaloes and cows in most cases are caused by BPXV (Yadav et al., 
2010). However, in 1967, for the ﬁrst time, virus was isolated from Northern India and still is 
related with sporadic outbreaks in Asian buffaloes in Bangladesh, Pakistan, India, Egypt, 
Russia, Nepal, Indonesia and Italy (Essbauer et al., 2010). The disease is characterized by 
appearance of local pocks, severe in nature, on the skin of udder and teats that leads to 
mastitis thus decreasing milk production of the animals (40-70% reduction), and 
consequently having direct economic loss to the dairy industry (Essbauer et al., 2010).  
2.4. Clinical signs and lesions 
 Incubation period in humans (3-19 days) is comparatively longer than in animals (2-4 
days) (Ghosh et al., 1977). The disease can be generalized or localized with mild to severe 
form and linked mostly with mastitis in nearly 50% of BPX affected animals. Cutaneous 
eruptions all over the body and local erythema from 7-day post infection (DPI) to 25-DPI 
were observed when female buffaloes were experimentally inoculated via I/D route with 
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Egyptian-BPXV and full recovery from the disease within a month. The skin lesions are 
mostly found on less hairy areas like the base of the ear, the inguinal region and udder. 
Complications due to secondary bacterial invasion also produced otitis. 
 Lesions of pox are mainly found on the udder and teats of buffaloes and cattle. 
Comparable lesions are also found on the legs, face and hands of the workers having close 
contact with the infected animals (Muhammad et al., 1998; Chandranaik et al., 2011). 
Lesions are generalized in the severe form of the disease (Ramakrishna and 
Ananthapadmanabham, 1957; Chandra et al., 1987). On the other hand, lesions are restricted 
on the inguinal area, teats and udder in the mild form (Sharma, 1934; Singh and Singh, 
1967), on eyes, inner surface and base of the ear, and over the parotid (Bhatia, 1936; 
Wariyar, 1937; Mallick and Dwivedi, 1982; Mallick, 1988). General form of BPX disease is 
now uncommon as seen in the preceding years; on the other hand severe confined forms of 
the disease occur affecting the teats and udder. Managemental conditions under which the 
animals are more prone to any infection like unhygienic conditions, immunosuppressed or 
immunocopromised, it is noticed that re-infection might occur. Generally, in re-infected cows 
with pox like agents, the lesions are milder and smaller as compared with those observed in 
the cows inoculated for the 1st time (Rehfeld et al., 2013). The time between the infection for 
the first time and reinfection also affects the lesions severity. The animals reinoculated after 
240 days developed severe lesions compared with those observed in the animals re-
inoculated after 70 days. This indicated that the antibodies in the cows re-infected after 70 
days may possibly promote local protection (Rehfeld et al., 2013). In milch animals, 
infection leads to mastitis, and contributes towards decline in milk production and working 
competence of draft animals. Permanent drop in milk yield is also observed in severe mastitis 
cases (Singh et al., 2006a; Singh et al., 2007). Primarily affected animals are buffaloes, 
however, humans and cows are infrequently involved. In an epidemic of febrile illness, 
beside rashes in buffaloes and humans exhibiting lesions of pox, malaise, fever, axillary and 
inguinal lymphadenopathy, and pain at the site of lesions were observed in humans. Affected 
buffaloes exhibited lesions on eyelids, external ears, udder and teats (Gurav et al., 2011). 
Buffalopox outbreaks have been recorded from several countries of the world (Essbauer et 
al., 2010), but now, a different trend has been noticed in Brazil, wherein outbreaks of 
VACV-like agents viz. Aracatuba viruses (Trindade et al., 2003) and Cantagalo (Damaso et 
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al., 2000) similar to pox-like-infections have been recorded. In experimental production of 
BV in cow, lesions developed only on the site of inoculation, whereas non-inoculated 
scraped teat did not develop lesions during the trial. However, VACV-DNA was observed in 
swabs of ulcers in the oral mucosa of immunosuppressed and infected animals, suggesting 
proliferation of VACV and its systemic dissemination in cows who were immunosuppressed. 
Lesions developed in the same pattern as in natural infections (Rehfeld et al., 2013). First 
there was papule formation, then vesicle stage, after that ulcers and scabs; at last the stage of 
healing (Lobato et al., 2005; Trindade et al., 2006; Rehfeld et al., 2013). 
2.5. Morphology of virion 
 Electron microscopic study of BPXV and other OPXVs has made known their 
structural resemblance among themselves. Size of BP4 (India) isolates of BPXV and Giza 72 
(Egypt) was observed to be 270x700x100 A° (Skalinskii and Tantawi, 1974). No difference 
in appearance was found between BPXV isolates of Egypt and India or among VACV and 
BPXV. In chorioallantoic membrane (CAM), a range of developmental stages of the virus, 
like method of discharge of mature virion (M- and C-forms), are perhaps similar to VACV 
(Skalinskii and Tantawi, 1974; Bloch and Lal, 1975). Mature virion is brick in shape 
measuring 200-250 nm x 280-330 nm (Bloch and Lal, 1975; Lal and Singh, 1977; Mohanty 
et al., 1989). On the other hand, it appears spherical or oval with or without a central core in 
the cytoplasm during its developmental forms (Bloch and Lal, 1975; Sehgal et al., 1977). The 
BPXV intracytoplasmic inclusion bodies of B-type are similar to inclusion bodies of CPX 
virus (CPXV), however, these show dissimilar appearance from Guarnieri bodies found in 
case of VACV, that are plentiful, small, asymmetrical, granulated and eosinophilic (Singh 
and Singh, 1967; Chandra et al., 1987).  
2.6. Physical and chemical properties 
 The BPXV is sensitive to heat, bile salts, chloroform and pH but resistant to ether 
(Lal and Singh, 1977). At 56oC in 90 min, BPXV reference strain-BP4, lost its total 
infectivity (Chandra et al., 1987), whereas BPH-80 strain exhibited a decline in titer of 
infectivity as log10 2.74 at 56oC in 30 min and entire loss at 56oC in 60 min (Kumar et al., 
1987). With a velocity constant (K) of 0.31, virion inactivates in a single-component manner 
according to 1st order exponential kinetics. In the presence of bivalent cations, thermal 
inactivation analysis showed better inactivation rate. The BP4 strain of BPXV failed to 
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produce lesions of pock at 40.5+0.5oC on CAM while VACV and BPXV BPH-80 strain 
being susceptible to high temperature, produced pock lesions. On the other hand, at 
38+0.5oC, all the three viruses (BPH-80, VACV and BP4) produced lesions of pock (Kumar 
et al., 1987). 
2.7. Cytopathology 
 Period of appearance of cytopathic effects (CPEs) after infection with BPXV reduces 
to 48 hours following five-passages in buffaloes and nine-passages in boys isolates when 
grew them in primary chicken embryo fibroblast (CEF) cell culture (Ramanan et al., 1996). 
In another study, results showed that Vero cell culture adapted BPXV completely attenuated 
at 40th passage for buffaloes and rabbits. It induced high level of humoral and cell mediated 
immune response in buffaloes as well as in rabbits (Mohanty and Rai, 1989). 
2.8. Serological associations and immunology 
 Immunologically OPXVs are cross-protective and cross-reactive; therefore protection 
against infection is attained after infection with any other member of the genus. This was 
explained by Edward Jenner in 1798/1799 by experimentation, for the very ﬁrst time. 
Afterwards VACV ‘‘the’’ vaccine to eradicate smallpox. In Latin, VACV means ‘‘vacca’’ 
for cow, however it is doubtful if VACV actually originates from cattle (Essbauer et al., 
2010). Vaccinia virus is the best studied of the poxviruses. It has been studied extensively as 
a model to understand the basic biology, virulence, and host range of poxviruses as well as its 
induction of host immune responses. Due to the fact that it usually causes only mild 
infections in humans and can induce protective immunity against other OPXVs, it was used 
successfully in the campaign to eradicate smallpox, after its immunization, by WHO in 1977 
(Smith, 2007). Edward Jenner suspected that the viruses he used for his immunization 
experiments were initially transmitted from horses, suffering from a once common disease 
called grease, to their human handlers. The handlers, he reasoned, subsequently transferred it 
to the udders of cows, which then infected the milkmaids. Since the milkmaids who provided 
the infectious material for his initial experiments acquired it from cows, Jenner called the 
infectious entity ‘‘cow pox’’ (Jenner, 1798). It should not be confused with current CPXV, 
which form phylogenetically distinct clades from VACV (Bratke et al., 2013). In later 
experiments Jenner showed that material extracted from the grease of horses, directly 
provided protective immunity against smallpox infection (Jenner, 1798).  
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 Cross-precipitation and cross-neutralization tests prove close association between 
VACV and BPXV (Singh and Singh, 1967; Kataria and Singh, 1970; Baxby and Hill, 1971; 
Lal and Singh, 1973). In gel diffusion tests, BPXV shows cross-reaction with goatpox virus 
(GTPV), fowlpox virus (FPV) and sheeppox virus (SPPV) (Mathew, 1975). In 
hemagglutination inhibition (HI) test, serum against BPXV also shows cross-reaction with 
FPV, however rabbit anti-VACV serum do not react with FPV (Mathew, 1975). Conversely, 
no cross-precipitation was observed between swinepox virus (SWPV) and BPXV in gel 
diffusion test, even sharing same nucleoprotein (NP) antigen in immunoelectrophoresis (IEP) 
and agar gel precipitation (AGP) tests (Kataria and Singh, 1970; Baxby and Hill, 1971; Lal 
and Singh, 1973). When rabbits were inoculated with BPXV, the serum precipitating and 
neutralizing antibodies appeared at 10-DPI, where as hypersensitivity reaction of delayed 
type (DTH) was observed day 12 onwards. In the experiments of Rehfeld et al. (2013) 
seroconversion occurred in cows injected with VACV at 10 and 16-DPI. Until end of the 
trial, high titers of neutralizing antibodies were observed. All cows produced anti-VACV 
antibodies, starting at the 10th and the 16th -DPI, respectively. In experimental production of 
BV in cow, hyperproteinemia and hyperglobulinemia was observed. This occurred due to the 
increase in antibody titers as the albumin values were in range of reference values (Rehfeld et 
al., 2013). Cellular as well as humoral immune response is important in revival from 
infection with BPXV (Chandra et al., 1990). The serological association among VACV, 
CPXV and BPXV by applying IEP test, serum neutralization test (SNT), complement 
fixation test (CFT) and agar gel immunodiffusion (AGID) test has been studied. The cross-
reactivity pattern in IEP and AGID tests was investigative of a close association of BPXV to 
VACV as compared with CPXV (Kataria and Singh, 1970). The pattern of precipitation 
found in AGID shows that BPXV shares four-antigens where as three in IEP with VACV. 
The SNT titers of rabbit serum against CPXV, BPXV and VACV were 8, 256 and 16, 
respectively. The BPXV was neutralized by antisera of CPXV and VACV at a 1:4 titer. 
Antisera of CPXV, VACV and BPXV further recognized a close antigenic association 
amongst these viruses due to cross complement-fixing (CF) and homologous activities. The 
BPXV, VACV and CPXV antigens were fixed by complement of rabbit anti-BPXV serum at 
1:640, 1:80 and 1:40 titer, respectively (Kataria and Singh, 1970). The facts stated above 
confirm the close antigenic associations among these viruses, but BPXV behaves in a 
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different way from CPXV and VACV in SNT even though bearing common antigenic 
components. In higher neutralization antibody titers using antisera of homologous nature and 
compared with those of heterologous origin, these differences are further manifested. These 
explanations advocate that BPXV is dissimilar from CPXV and VACV (Singh and Singh, 
1967; Baxby and Hill, 1969; Kataria and Singh, 1970) and should be categorized as a 
different entity inside the Vaccinia-Variola (VV) cluster of poxviruses. Singh et al. (2006a) 
witnessed BPX outbreak in buffaloes with considerable production loss of milk as well as 
high morbidity. A number of cases of human infection were also noticed, primarily in 
milkers working among the affected herds. Venkatesan et al. (2010) investigated a 
widespread outbreak of BPX involving many human cases. Significant productivity losses 
and high morbidity were recorded in domestic buffaloes. The disease inflicted decline in 
trade of animals and a loss of about 40% in terms of reduced milk production. Pox lesions 
were observed on all parts of the body but severe forms were noticed on the inner ear. This 
led to pyrexia and otitis in most of the affected animals. Milkers developed lesions of pox on 
the skin of forearms, hands, fingers, forehead, face and ears. The other signs were malaise, 
axillary lymphadenitis, lymphadenopathy along with pyrexia. Experiments in a closely bred 
population of mice on protective immunity did not show host versus graft reactions. 
Simultaneously passive transfer of rabbit anti-BPXV serum with a dose of 0.25 ml and later 
on challenge with 105 TCID100/ml with a dose of 0.05 ml of BPXV showed 57.15% and 
47.06% safety with a 1:2 and 1:16 serum dilutions, respectively. Passive transfer of 1:2 and 
1:16 dilutions of hyperimmune serum against BPX, 24h before giving challenge with BPXV 
conferred 87.50 and 75% safety, respectively. However, passive transfer of normal rabbit 
serum or physiological saline into mice did not protect them from lethal challenge with 
BPXV. The protection offered by spleen cells of immune donor mice with the doses of 
5x106, 10x106 and 15x106 was 37.5%, 42.85% and 50.0%, respectively. Mice receiving 
spleen cells of donors immunized with physiological saline emulsified in Freund's 
incomplete adjuvant did not survive lethal challenge with BPXV. On the 4th, 5th and 7th DPI 
with BPXV, peripheral blood of rabbits revealed transient relative lymphopaenia regarding 
T- and B-cells. However, on the 14 and 21 DPI, these values returned to normal. Percentage 
of B cells or absolute B-cell number showed non-significant difference between infected and 
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control rabbits. Both humoral and cellular immunity played a role in recovery from BPXV 
infection in rabbits and mice (Kaushik and Pandey, 1980).  
2.9. Buffalopox or bovine vaccinia 
 Due to a long passage history and selection for cell-culture adapted and less virulent 
VACV strains, the genomes of VACV strains are highly heterogeneous, mainly due to large 
deletions. Experimental infections showed that several VACV strains can productively infect 
many hosts, including primates, rodents, lagomorphs and ungulates. VACV has also been 
successfully used to immunize zoo and circus animals against other OPXVs (Essbauer et al., 
2010). The VACV can occasionally also be transmitted from recently vaccinated humans to 
other human contacts and cause serious illness, including death, especially in 
immunocompromised people. Moreover, fetal VACV infection, transmitted from a mother to 
her fetus can result in rare, but lethal (Cono et al., 2003; Sepkowitz, 2003). Orthopoxviruses 
that are closely related to VACV have repeatedly caused severe disease in Asian buffaloes 
and are therefore sometimes referred to as BPXV, which occasionally cause zoonotic 
infections in humans (Essbauer et al., 2010; Moussatche et al., 2008). Phylogenetic analyses 
of a small number of genes from these viruses show a close relationship of BPXV to VACV 
strains, which makes it likely that they represent descendants of escaped now-feral VACV 
(Yadav et al., 2010). Similarly, VACV-related viruses have caused disease outbreaks in 
Brazilian cattle and in human farmers (Essbauer et al., 2010; Moussatche et al., 2008). 
Closely related viruses, which are most closely related to VACV-like strains that caused 
outbreaks in cattle and humans, were also detected in capuchin monkeys (Cebus apella) and 
black-howling monkeys (Allouata caraya) by PCR and isolated from a wild house mouse 
(Mus musculus) in Brazil (Abrahao et al., 2009a; Abrahao et al., 2010). These ﬁndings 
indicate natural reservoirs for Brazilian VACV-like viruses that might have escaped during 
VACV vaccinations. However, more sequence data and additional phylogenetic analyses are 
necessary to conﬁrm the notion that BPXV and Brazilian VACV strains isolated from wild or 
domesticated animals indeed represent descendants of escaped vaccine-derived VACVs. 
Infection in cows by VACV is known as bovine vaccinia (BV). It increases susceptibility to 
secondary bacterial pathogens leading to mastitis and signiﬁcant decreased milk production 
(Trindade et al., 2003; Lobato et al., 2005). In natural infections of BV in cows, lesions on 
the skin of udder and teats, start with red papules, developing to vesicles. After 3-4 days, 
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lesions turn into umbilicated pustules bordered by inﬂammatory tissue. After that these 
pustules turn into ulcers, until complete healing of wound is there. Calves that suckled 
affected cows, developed lesions on the mouth, muzzle and lips (Trindade et al., 2008). 
Infection in humans is described by appearance of pustules and ulcers on the face, forearms 
and hands, along with lymphadenopathy, pain and fever (Lobato et al., 2005). Studies found 
the infectious virus and VACV DNA in milk of cows with natural infection (Abrahao et al., 
2009b). Furthermore, infectious VACV was isolated from cheese and it’s by products formed 
with milk of experimentally infected cow (de-Oliveira et al., 2010). In Brazil, no cases of 
human VACV infection were observed consuming milk from affected animals. However, a 
strain of VACV i.e. BPXV, producing infection in buffaloes in India, was identified as the 
causative agent of oropharyngeal lesions in humans consuming milk that was unpasteurized 
(Berkelman, 2003). 
 Historically, the designation CPXV was used to describe OPXVs that infect cows and 
were occasionally transmitted to humans who had close contact with infected cows. 
Characteristics of CPXV, although not speciﬁc, are the formation of cytoplasmic A-type 
inclusions, which contain mature virions embedded in a matrix formed by the late viral 
protein ATI, and the formation of large hemorrhagic pocks on the chorioallantoic membrane 
(Essbauer and Meyer, 2007). CPXVs have the broadest host-range among known poxviruses. 
Their reservoir hosts are likely rodents including many vole and mouse species. CPXVs 
naturally infect many other species including cats, dogs, cows, horses, primates, including 
humans, and a diverse set of zoo animals such as elephants, rhinoceroses and big cats. Most 
human CPXV infections are caused by contact with infected cats or pet rats, through skin 
lesions. Whereas infections in immunocompetent individuals are usually localized, 
immunocompromised patients, including those suffering from atopic skin diseases are at 
higher risk for systematic and even fatal infections (Essbauer and Meyer, 2007; Essbauer et 
al., 2010). Phylogenetic analyses using concatenated protein alignments from conserved 
genes showed that CPXVs form clearly distinct clades from VACV (Bratke et al., 2013). 
2.10. Molecular biology 
2.10.1. Polypeptides of the virion 
 Analysis of polypeptides of purified BPXVs, have been done by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The polypeptide profiles of 
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purified BPXV isolated from a human isolate and of buffaloes from India, and VACV strain 
WR yielded 19, 26, and 29 polypeptides, respectively (Maan and Kalra, 1995). Out of these, 
7, 3 and 6 polypeptides of VACV, BPXV of human-origin and BPXV of buffalo-origin, 
respectively, were glycoprotein in nature. These isolates exhibited 4, 4 and 5 major 
polypeptides, respectively, with molecular weights in the range of 14.2 to 347 kDa. Isolate 
from buffaloes and from human shared four polypeptides (14.6, 18.2, 26 and 42 kDa), while 
VACV shared only one polypeptide (18.1 kDa) with isolates of BPXV. Conversely, all three 
viruses shared two glycoproteins (14.8 and 26 kDa). Additionally, one glycoprotein (42 kDa) 
was a common major protein between BPXV of human origin and BPXV of buffalo origin. 
Hence, polypeptide mapping, did not give definite information regarding antigenic 
associations among these viruses. Singh et al. (2006b) recognized, in 12% SDS-PAGE, the 
polypeptides of three BPXV isolates from India and the reference virus (BP4), which 
revealed that all four isolates of BPXV were alike and contained more than 25 polypeptides 
having molecular weights in the range of 14.2 kDa to >180 kDa. Production of polypeptides 
(early and late) of these viruses may possibly be tracked in vivo by labeling with 35S-
methionine. In another study, as a preliminary work, the field isolates of BPXV recovered 
from suspected clinical materials obtained from outbreaks of different geographical locations 
of India were propagated in Vero cells and purified along with reference BP4 virus for 
comparison. Purification of BPXV was carried out in sucrose density gradient (60-36%), 
where two white opalescent bands appeared after ultracentifugation. The upper band, above 
the 36% sucrose layer was found to be enveloped virus (Extra cellular enveloped virus) 
where as the band at interface was the pure naked virus (Intracellular Mature Virus). The 
purity of the virus preparations was assessed by UV-spectrophotometry,   SDS-PAGE and 
infectivity assay in cell culture. The extinction ratio values (O.D. 260/280) for all the BPXV 
isolates were within the range of l.2 to 1.4 indicating highly purified nature of the BPXV. On 
the basis of polypeptide compositions, BPXV isolates were similar and contained more than 
25 polypeptides with a molecular weight range from 14.2 kDa to 180 kDa. Both the 
opalescent bands produced characteristics CPE in Vero cell line in infectivity assay. This 
preliminary study will help in undertaking further work on protein profile and further 
characterization, which, in turn, will help in understanding the virological and immunological 
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properties of the new virus isolates for development of suitable immuno-diagnostics and 
prophylactics (Singh et al., 2006b). 
2.10.2. Restriction enzyme analysis of viral DNA 
 Thirteen isolates of VACV and BPXV revealed alike on the basis of restriction 
enzyme (RE) profiles using digestion with Hind-III. However, in India twelve BPXV isolates 
from Maharashtra might be differentiated from strain of Hisar and three strains of VACV 
(King Institute, Madras; Patwadangar, Nainital and U.S.S.R.). Twelve isolates of BPXV 
show repetitive isolations. On the basis of biological properties, one of these BPXV isolates 
was identical to VACV, but different from three VACV strains in RE profile (Dumbell and 
Richardson, 1993). RE analysis using Hind-III, EcoR-I, BamH-I and Pst-I enzymes found 
that BPXV, SPPV and GTPV are clearly dissimilar from each other (Bhat et al., 1993). 
However, RE profiles of BPXV generated by Pst-I, BamH-I and Hind-III were identical with 
VACV. BP4 strain of BPXV was different from ‘A strain’ of BPXV on the basis of Pst-I 
profile studied by Baxby and Hill (1971) and three strains of smallpox vaccine virus formerly 
used in India. These outcomes established the genome regions-conservation among OPXVs 
including BPXV, CPXV and VACV (Esposito and Knight, 1985; Pilaski et al., 1986). The 
thymidine kinase (TK) gene in BP4 strain was confined in the BPXV genome in BamH-I, 
Hind-III and two EcoR-I fragments, when hybridized to TK probe of cloned VACV. Weak 
TK hybridization signals between BP4 strain of BPXV and capripox virus have also been 
verified, demonstrating TK homology between the capripox and orthopox groups of viruses 
(Bhat et al., 1994). 
2.10.3. Homology, variation and phylogenetic analysis of virion 
 The OPXV genus comprises some of the best-studied poxviruses. The genomes of 
many OPXV species and strains have been completely sequenced, which provides valuable 
insights into the evolution of OPXVs. Orthopoxviruses are closely related to one another 
antigenetically, which results in cross-reactivity and cross-protection against recurrent OPXV 
infection. Among the OPXVs are two of the most renowned viruses: VARV, which caused 
human smallpox, and VACV, which has been successfully used in the campaign for the 
eradication of VARV (Haller et al., 2014). Evolutionary associations among the closely 
related species of viruses are best studied by sequence analysis on the basis of nucleotide (nt) 
and amino acid (aa) sequences of the viruses. Now a number of OPXV sequences are 
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available in the database. Sequence homology among the Old World OPXVs is ~ 95%. In 
contrast, about 75% genomic DNA homology was found between OPXVs isolated in North 
America and Old World OPXVs. When OPXVs are divided into two groups, Group-1 consist 
of Old World VACV (beside its variants: BPXV and rabbitpox virus), ectromelia virus 
(mousepox) and MPXVs. Group-2 comprise of VARV (the causative agent of smallpox), 
skunkpox, tatera gerbilpox, racoonpox (RCNV) and camelpox viruses (CMLVs). Both these 
groups have a genetic association with a different group of CPXVs, keeping an idea that all 
of the OPXVs might evolve from an earliest CPXV (Safronov, 2004). A number of VACV 
variants escaped into animal populations, and currently circulate in nature. A few of variants 
of vaccinia caused disease in man, like in India BPX is due to variants of VACV, a number 
of theses have been distinguished (Dumbell and Richardson, 1993; Singh et al. 2007). 
Several BPXV genes have been sequenced to determine the association of BPXV with other 
member species of OPXV that play very important roles either in morphogenesis or 
pathogenesis like recognized in the model of VACV. These comprise major genes of 
envelope of BPXV homologues of genes of VACV, viz. envelope proteins that bind 
chondroitin sulfate (D8L) and cellular heparin sulfate (A27L and H3L). These genes take 
part in attachment and cell entry for VACV (Chung et al., 1998; Hsiao et al., 1999; Lin et al., 
2000). The BPXV-C18L gene, a VACV homologue, encoding ankyrin repeat protein was 
analyzed by sequencing to explain its genetic relationship to that of VACVs and also to 
develop a PCR strategy for BPX diagnosis. Sequencing of C18L gene of BP4 strain of BPXV 
exposed the truncated ankyrin protein with a coding region consisting 50-aa as compared 
with a 150-aa-long peptide expressed by Copenhagen strain of VACV. Comparison of C18L 
gene sequences of isolates of BPXV to that of available data of the genus OPXVs showed 
35.5% to 67.1% at aa level and 71.2%-77.3% homology at the nt level with VACVs. 
Moreover, TaqMan assay was proved to be specific, rapid and 100 times more sensitive with 
a detection limit as low as 5 pg of viral DNA in comparison with the conventional PCR of 
OPXVs (Singh et al., 2008). 
 More than 99% sequence homology of nucleic acid sequences of selected genes of 
isolates of BPXV have been shown not only among themselves but also with VACV. Several 
substitutions were identified in the genes that were unique both to VACV and BPXV among 
all OPXVs. Phylogenetic analysis of structural protein genes including B5R (Singh et al., 
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2007) and A27L, D8L, H3L (Singh et al., 2006b) and non-structural protein homologue gene 
to H4L, that are extremely conserved across the genus, revealed that BPXV is closely related 
to vaccinal strains of VACV (Dumbell and Richardson, 1993; Singh et al., 2006b). In recent 
times, samples collected from outbreaks where only cows or at the same time both buffaloes 
and cows were affected were analyzed. Among these isolates a few were adapted in Vero 
cells and analyzed by restriction fragment length polymorphism (RFLP), polymerase chain 
reaction (PCR), sequencing and electron microscopy (EM). For phylogenetic analysis, the 
sequence of the HA gene was determined from eight virus isolates. In the OPXV species 
differentiation, the HA gene is useful (Ropp et al., 1995; Damaso et al., 2000). The HA gene 
sequence analysis discovered that in cows the majority of the pox-like outbreaks were caused 
by BPXV, meaning a broader host range of virus apart from humans and buffaloes. Isolates 
of buffaloes and cows shared high sequence homology (> 98%) between them. These isolates 
also exhibit high sequence identity with other homologous gene sequences of various OPXV 
species available in database of GenBank. Among OPXVs, they shared 94.6–98.7% and 
97.2–98.9% sequence resemblance with that of VACV at aa and nt levels, respectively. In 
Brazil similar outbreaks of disease in humans and cows were caused by Cantagalo virus 
(Damaso et al., 2000; Nagasse-Sugahara et al., 2004) and Aracatuba virus (Trindade et al., 
2003) that on the basis of phylogenetic analysis have shown close relation with VACV. In a 
comparison, sequence homology of 97.2-98.9% of BPXV isolates with VACV strains is 
reported where as Aracatuba virus showed 95.7– 96.4% identity with VACV. Phylogenetic 
analysis of aa sequence of the HA genes also confirmed this relationship. In this way, isolates 
of BPXV are more closely linked to VACV than Aracatuba virus to VACV. Additionally, 
deletions of six codons between nt 249 and 254 were also seen in Aracatuba virus in 
comparison to VACV or BPXV sequences. However, phylogenetic analysis of full genome 
will present more convincing proof of BPXV isolates in the light of previous explanations 
that the BPXV is a clade of VACV. Sequence analysis of the C18L gene of BPXV 
homologue to that of VACV discovered noticeable changes in comparison with 
corresponding VACV sequence. Comparative sequence analysis of C18L gene of isolates of 
BPXV to that of published data of OPXVs revealed that there is 71.2-77.3% homology at the 
nt level and 35.5-67.1% at the aa levels with VACVs (Singh et al., 2008). Phylogenetic 
analysis based on three genes also conﬁrmed that BPXV is closely related to VACV; 
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taxonomically it is like the other two agents a strain of VACV (Singh et al., 2006). Sequence 
analyses of haemagglutinin (HA) and A-type inclusion (ATI) genes isolated form buffaloes 
and cattle, show their close association with other OPXVs (Bhanuprakash et al., 2010; Yadav 
et al., 2010; Chandranaik et al., 2011). The Hind-III restriction analysis of DNA of scabs 
collected from lesions of pox in buffaloes gives identical profiles with three endonucleases 
having been repetitive isolations of a single strain of BPXV. These interpretations took 6-8 
years after ending of immunization against smallpox vaccine and indicate that infection with 
BPXV is rising, further it is a subspecies of VACV (Dumbell and Richardson, 1993). 
Phylogenetic studies of C18L and ATI genes show that in India, a single viral strain is 
circulating (Gurav et al., 2011). Contrary to this, in another study, sequence analysis of 
membrane protein gene (B5R) and host-range genes (C7L, K3L, E3L) of BPXVs from 
human, cattle and buffaloes reveals that aa sequences of K3L and E3L genes are 100% 
similar in isolates of human, cattle and buffaloes but four major point mutations (D249G in 
B5R gene and, S36F, N12K and I11K in C7L gene) are present in isolates of buffaloes. 
Therefore, indicating circulation of different strains of BPXV in buffalo population (Bera et 
al., 2012). 
2.11. Epidemiological relationships 
Poxviruses as a group can infect a large number of animals. However, at the level of 
individual viruses, even closely related poxviruses display highly diverse host ranges and 
virulence. For example, VARV, the causative agent of smallpox, is human-speciﬁc and 
highly virulent only to humans, whereas related CPXVs naturally infect a broad spectrum of 
animals and only cause relatively mild disease in humans. The successful replication of 
poxviruses depends on their effective manipulation of the host antiviral responses, at the 
cellular-, tissue- and species-speciﬁc levels, which constitutes a molecular basis for 
differences in poxvirus host range and virulence. A number of poxvirus genes have been 
identiﬁed that possess host range function in experimental settings, and many of these host 
range genes target speciﬁc antiviral host pathways (Haller et al., 2014). First occurrence of 
BPX was reported in 1934, after that disease has regularly been reported in buffaloes of 
different geographical locations. Mainly young and old buffaloes are affected in an epidemic; 
however, occasionally cattle have also been affected (Ghosh et al., 1977). In one study, 
disease prevalence rate of 10.13% was recorded, and it was found that there was no 
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significant difference between prevalence in adult females (13%) and males (13.63%), and 
young females (5.24%) and males (6.32%) (Kumar et al., 1987). In only one district of 
Pakistan, data based upon participatory appraisal and scanning surveillance, prevalence of 
BPX upto 50% in buffaloes has been reported (Khan, 2010). Complications due to secondary 
bacterial infections produced mastitis in 50% lactating buffaloes of affected herds. In 
Mandya and Mysore, a very high prevalence (23.4-79.4%) of BPX was observed 
(Muraleedharan et al., 1989). In Aurangabad (Maharashtra), morbidity rate of BPX up to 
45% was recorded (Singh et al., 2006a). Overall, case fatality, mortality and morbidity rates 
in another study on BPX are 11.4%, 0.7% and 6.8% respectively (Bhanuprakash et al., 
2010). In buffaloes, seropositivity of BPX upto 5.6% was observed from different areas of 
Egypt using CFT. Disease spread was fast in buffaloes, on the other hand, goats, sheep and 
cows remained unaffected in the same areas (Iwad et al., 1981). Biting flies possibly played a 
role as mechanical career for transmission of disease because flies including and Musca 
vicina, Musca crossirostris and Lyperosia exigua aggravated the sores. (Muraleedharan et 
al., 1989). In another outbreak, BPXV was isolated both from human cases and buffaloes. 
Phylogenetic analysis based on the ATI and C18L gene revealed that a single strain of virus 
is circulating in India.  
2.12. Hematological and serum biochemical analyses 
 Vaccinia virus is the causative agent of BV, an important zoonotic infection of cattle. 
Rehfeld et al. (2013) in the ﬁrst part of their study regarding BV, infected the lactating cows, 
with GP2 strain of VACV. In second part, previously infected animals with GP2 strain of 
VACV were placed into two groups: Group-1 comprised of cows who were 
immunosuppressed; and in Group-2, comprised of re-infected. In this trial, BV was 
reproduced experimentally, exhibiting similar pattern of lesion production as in natural. In 
addition, lymphadenopathy and a short incubation period were also recorded. Vaccinia virus 
was identified by PCR from scab lesions of teats of all animals that were inoculated and re-
inoculated. In the 1st part of trail, neutrophilia and lymphocytosis were found in all the 
animals. Microscopic analysis of blood revealed the presence of reactive lymphocytes. In 2nd 
part of trial, an intense leukocytosis with severe lymphopenia and neutrophilia were observed 
in animals that were treated with dexamethasone (DMS). The levels of leukocytes returned to 
their normal, in last days of experiment. In the group having re-infected cows, hematological 
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changes were not found. Very short incubation period of 3 to 4-DPI was observed. Lauder et 
al. (1971) also stated an incubation period of 2 days. Disease lasted until 22 to 27-DPI, but in 
one cow, it was until 32-DPI. However, Lobato et al. (2005) reported that in cows of natural 
infection with pox viruses, the duration of disease ranged from 15 to 30 days. It should be 
noticed that heterogeneity of age, race, body condition, individual factors and herd possibly 
inﬂuence the time of healing. Recurrence of vesicles in the same teat point out that in the 
same outbreak infection could occur again, and for these events, milkers might act as a risk 
factor. In hematological tests of BV infected cows, small concentrations of reactive 
lymphocytes alongwith lymphocytosis were observed, which advocate a response to viral 
agents. Neutrophilia in all the animals could be due to mastitis (Paes et al., 2009; Rehfeld et 
al., 2013). In experimental production of BV in cow, no changes were observed in assays of 
kidney and hepatic functions, proposing that replication of virus did not hinder kidney and 
liver functions (Rehfeld et al., 2013). 
2.13. Host range genes 
 Approximately 50 relatively conserved genes are found in all sequenced poxviruses 
and another 40 genes are present in most chordopoxviruses (Lefkowitz et al., 2006). These 
genes are important for the general biology of poxviruses such as transcription, RNA 
processing, replication and virion assembly and are generally found in the central regions of 
the genomes. Genes that are involved in the interaction with the host map generally present 
towards the terminal regions of the genomes and often exhibit lower sequence identity and 
lineage-speciﬁc distribution. Many but not all, of these genes, are dispensable for virus 
replication in cell culture, but viruses that have been engineered to lack them are usually 
attenuated in infection models. Therefore these genes are referred to as virulence genes, and 
their protein products as virulence factors. A striking feature of chordopoxviruses, is that the 
range of host species that can be productively infected by a given virus, referred to as host 
range, can vary drastically even between closely-related species within a single genus 
(McFadden, 2005). Among OPXVs for example, VARV, the causative agent of smallpox, 
was strictly human-speciﬁc before its eradication, whereas CPX and MPXVs naturally infect 
a wide variety of mammalian species and therefore possess relatively broad host ranges. 
Remarkably, most poxviruses can enter a large variety of cells from many different animal 
species in a fashion that is mostly independent of species-speciﬁc receptors and involve 
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virion proteins that are conserved in all poxviruses (Moss, 2006). Virus replication and 
establishment of permissive infection requires the successful manipulation of the host 
antiviral immune system, especially, the innate immune responses. Certain poxvirus genes 
have been identiﬁed, which are important for viral replication in a subset of cells or host 
animals, whereas they are dispensable in others. Genes that are important for poxvirus-
speciﬁc differences in host range can be referred to as host range genes (McFadden, 2005). 
Until now, approximately 15 genes have been identiﬁed in different poxviruses that possess 
host range function (Werden et al., 2008). Deletion of those genes leads to viral replication 
defects in a subset of normally permissive cells. Known poxvirus host range genes can be 
grouped into 12-distinct-gene families. Some of these families contain only one member, 
whereas others contain many members, likely resulting from lineage-speciﬁc duplications. 
Poxviruses are pathogens which are widespread in nature, displaying very different range of 
hosts. But some of them, like VARV, exhibit narrow range of hosts, and CPXV naturally 
infect a broad range of mammals. Differences in host range, on molecular basis are poorly 
understood but in fact depend on successful manipulating host antiviral response. In 
experimental settings, a few genes of poxviruses presented host tropism and, therefore called 
factors for host range. Host range genes that have been identiﬁed, include VACV B5R, C7L, 
E3L, K1L, K3L and SPI-1, ectromelia virus p022 and 28, CPXV CP77/CHOhr, and myxoma 
virus 11L, 13L, T2, T4, T5, 062R and 063R. These genes encode for different proteins like, 
ankyrin repeat-containing proteins, apoptosis inhibitor T4-related proteins, tumor necrosis 
factor receptor II homologs, Bcl-2-related proteins, pyrin domain-containing proteins, short 
complement-like repeats containing proteins, cellular serine protease inhibitors (serpins), 
KilA-N/RING domain-containing proteins, and inhibitors of the double-stranded RNA-
activated protein kinase PKR (Bratke et al., 2013). Interestingly, not a single host range gene 
has been identiﬁed that is present in all poxviruses. On the contrary, the majority of host 
range genes show evidence for multiple independent lineage-speciﬁc inactivation events, 
which indicates that those genes might have been dispensable for virus replication in their 
respective hosts. Alternatively, gene inactivations might have provided the virus with a 
selective advantage by causing its attenuation and making its infected host less sick.  This 
could lead to better host survival and increased mobility, which could in some cases lead to 
better virus transmission. The precise molecular mechanisms of how host range genes 
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inﬂuence poxvirus host range, are only partly understood. Different molecular mechanisms 
for host range function are possible. Since host range proteins often antagonize the host cell 
innate immune system, the mere presence or absence of host range genes can lead to 
successful replication or replication defects in different animals or their derived cells. Many 
host range genes have been identiﬁed by the analysis of spontaneously arisen mutants and/or 
targeted gene deletions that resulted in altered growth characteristics and host range, as 
compared to their progenitors. Examples of this include the spontaneous deletions 
comprising the serpin gene SPI-1 in rabbitpox virus (RPXV) and K1L in VACV that were 
subsequently conﬁrmed by targeted deletions (Gillard et al., 1986; Ali, et al., 1994). All 
deletions of host range genes analyzed so far have resulted in the restriction of the virus host 
range, however theoretically, the deletion of at least certain genes could also result in 
extended host range, e.g. if a host-derived molecule targeted a viral gene product and thereby 
mediated the induction of an antiviral response only in cells possessing that factor. 
2.14. Virus spread 
 At present, a little is known about the ankyrin/F-box protein B4. However, in a study 
of VACV (a homologue of BPXV), B4R-null viruses, in tissue culture system showed 
decreased plaque size, and reduced ability to spread, as evaluated by growth analysis on 
multiple steps. Electron microscopic studies showed that B4R-null viruses still formed 
extracellular and mature virions. Though, slight decline in release of virion was there, into 
the media after deleting B4R. Removal of B4R, not affected the capability of virus to 
rearrange actin. Whereas, VACV811; a deletion mutant, missing 55 open reading frame 
(ORF), showed decreased capacity to make actin. By using ectromelia virus i.e. a mouse 
pathogen in nature, they confirmed that virus devoid of EVM154, the B4R homolog, was 
attenuated during process of infection and it exhibited decreased capacity of spreading to 
different organs. This initial categorization proposed that B4 might play a role in spreading 
of virus, and that other unrevealed mediators which are involved in formation of actin tail, 
might exist in VACV (Burles et al., 2014). 
2.15. Poxvirus host switches 
 Current knowledge is insufficient to accurately predict the outcomes and 
consequences of poxvirus host switches such as virulence, transmissibility and whether 
persistence within a new host species can be established.  This is complicated by the problem 
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that for many poxviruses, the reservoir host-species have not been unequivocally identiﬁed. 
Many poxviruses cause only mild disease in their respective reservoir hosts, probably 
reﬂecting sufficient time for host-virus co-evolution. However certain patterns for host 
switches can be observed that are  helpful  for  a  better  understanding  of the effects of this 
important subject: host switches  involving more distantly related species tend to cause 
relatively milder disease, whereas those involving more  closely  related  species can lead to 
disastrous outcomes (Haller et al., 2014). Poxviruses from the three genera yatapoxvirus, 
PPV and OPXV can cause zoonotic infections in humans. In most cases those infections are 
relatively mild, localized and poorly transmissible among humans, with the notable exception 
of MPXV Congo basin strains, which can cause mortality rates of approximately 10% 
(Essbauer et al., 2010). Additionally, many poxviruses can infect other animal species in 
addition to their natural host(s). This includes CPXVs, which probably infect rodents as their 
reservoir hosts but have been isolated from many animals belonging to various mammalian 
orders (Essbauer et al., 2010). 
2.16. Zoonosis 
 Buffalopox is an important viral infection and contagious in nature that occurs in 
buffaloes of all age groups, in epidemic proportions in countries including Bangladesh, 
Egypt, India, Indonesia, Italy, Russia and Pakistan where buffaloes are reared (Essbauer et 
al., 2010). Buffalopox was declared infection of zoonotic importance by the Joint Expert 
Committee on Zoonosis. This committee put emphasis on transmission mode of BPX to 
humans and recommended that other epidemiological factors seem to be similar to that of 
CPX (Chandra et al., 1987). The BPXV is a VACV variant that can infect man (Dumbell and 
Richardson, 1993; Singh et al. 2007). Humans including smallpox-vaccinates got infected on 
close contact with BPXV infected animals, however the degree of disease severity is greater 
in individuals who are non-immunized (Singh et al., 2007). Humans who touch the BPX 
infected teats of dairy cows or buffaloes, can contract skin disease, although systemic 
symptoms are generally absent or quite mild in nature. Drinking of unpasteurized milk 
carrying the BPXV also causes oropharyngeal lesions in the people (Dumbell and 
Richardson, 1993; Lewis-Jones, 2004). Occasionally, the appearance of gross lesions has 
been recorded in human beings, maintaining close proximity with pox-affected buffaloes, 
milkers and attendants (Wariyar, 1937; Ghosh et al., 1977; Mehrotra et al., 1981; Mitra and 
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Chatterji, 1986; Kumar et al., 1987; Kolhapure et al., 1997; Raut et al., 1997; Jain, 1998; 
Singh et al., 2006a). Appearance of lesions is generally confined to the face, forehead, hands, 
buttocks and legs. Lymphadenopathy has also been observed, however infrequently. 
Transmission from human-to-human has not been seen. After detailed analysis of a BPX 
outbreak in India (Maharashtra), it was suggested that (i) the antibodies detection in humans 
might be a sign of subclinical illness that may lead to the general population to expose to the 
BPXV (ii) the antibodies detection in 17% of persons having no contact either with infected 
humans or buffaloes and 70% of in-contact persons is a concern of public health (iii) in 
humans, the virus may get virulence following continual passages, as is obvious from the 
comparison of the BP4 strain (reference strain) isolated 40 years ago and BPXV strains of the 
Maharashtra outbreak, India (Kolhapure et al., 1997). One of the major modes of spread was 
the milking of affected animals by same workers. In view of that, 28% of milkmen were 
affected; including children aged 8 and 11 years, in a Dhulia district, India. Comprehensive 
survey of 30 families in six villages having BPX cases showed that BPX attacks affected up 
to 69.7% of the milkmen. Out of 39 persons who developed pox lesions, 23% were having 
primary vaccination whereas 64.1% were having primary as well as booster vaccination 
(Ghosh et al., 1977). In the past, BPXV was considered host specific infecting only buffaloes 
however, in biological transmission experiments on BP4 strain of BPXV it was observed that 
if BPXV given in a high dose, it might be transmitted to cow calves (Singh et al., 1996). 
Sequencing of inclusion A-type inclusion (ATI) and HA genes of viruses isolated from cows 
affected with pox-like disease were characterized and found that the causal agent was not 
CPXV but BPXV (Yadav, 2006) indicating cross infectivity. In 2004-2005 during 5 months, 
BPX infection was confirmed by isolation of virus and sequencing of nucleic acid. It spread 
among 5 burn units of hospitals of Karachi city in Pakistan. Admitted patients exhibited 
lesions of pox at the sites of burn wounds and the intact skin was surrounding them. The 
source of infection was buffalo fat that was contaminated by VACV. This fat was used as 
ﬁrst-aid material for covering the burns in field conditions. Inspite of the tragedy and irony of 
these infections, it demonstrated an indirect and efficient mode of transmission of OPXV. 
The outburst was related to movement of patients between units indicating possible man to 
man transmission. Disease transmission was reduced by adopting control measures, however 
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sporadic cases continued due to the admittance of new patients with community-acquired 
infections (Zafar et al., 2007). 
Venkatesan et al. (2010) investigated a widespread outbreak of BPX involving many 
human cases. Significant productivity losses and high morbidity were recorded in domestic 
buffalo. The disease inflicted decline in trade of animals and a loss of about 40% in terms of 
reduced milk production. Pox lesions were observed on all parts of the body but severe forms 
were noticed on the inner ear. This led to pyrexia and otitis in most of the affected animals. 
Milkers developed lesions of pox on the skin of forearms, hands, fingers, forehead, face and 
ears. The other signs were malaise, axillary lymphadenitis, lymphadenopathy along with 
pyrexia. Singh et al. (2006a) witnessed BPX outbreak in buffaloes with considerable 
production loss of milk as well as high morbidity. A number of cases of human infection 
were also noticed, primarily in milkers working among the affected herds. Kolhapure et al. 
(1997) detected neutralizing antibodies in the sera of pox affected persons and in their 
contacts. Individuals of endemic area exhibiting antibodies, having not been vaccinated 
against smallpox or history of any poxvirus disease or not having any contact with buffaloes, 
is indicative of incidence of subclinical illness. Children having no contact with infected 
animals also exhibited lesions on the arm, face, and buttocks, perhaps acquired illness from 
their infected family members representing a possible man to man transmission. Considering 
the appearance and recurrence of BPXV in humans, cows and buffaloes, not merely in India 
but also in other buffalo rearing countries, regular monitoring of the outbreaks and control 
strategies are necessary to limit the economic losses and also to lessen the impact of the 
disease on public health (Venkatesan et al., 2010). 
2.17. Complications in pox infections 
 At the beginning of infection by poxviruses when there is erythema, edema, nodules 
or papules with appearance of blisters, e.g. beta- hemolysing Streptococcus of group A, 
Herpes simplex virus-1 and -2, Staphylococcus aureus, Neisseria pneumonia, Haemophilus 
inﬂuenzae, Bartonella henselae should be worried. In the advanced stage of infection, i.e. 
when crusts and ulcers are there, agents like Francisella tularensis, Bacillus anthracis, or 
Treponema pallidum should also be taken into consideration. Secondary infections by fungi 
and bacteria have also been reported from animal and humans. In the ﬁeld, mastitis has been 
observed as a common secondary infection, in cows infected with VACV (Lobato et al., 
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2005; Trindade et al., 2006) and in buffaloes by BPXV infection (Singh et al., 2007), that 
leads to decrease in milk production. Rehfeld et al. (2013) in his experiment with BV also 
observed that there was 32.94% decrease in milk production, indicating that BV affected 
dairy herds bear a huge economic loss. However, before and after milking, dipping of teats in 
antiseptic solutions, helps in prevention of diseases, like mastitis and herpetic mamilite 
(Almeida et al., 2008), BV and pseudocowpox (de-Oliveira et al., 2011). 
 In the scenario of pox infections, and treatment with antibiotics and steroid 
administration to avoid secondary bacterial pathogen complications, mostly causing mastitis, 
may lead to immunosuppression. Rehfeld et al. (2013) experimentally induced 
immunosuppression in cows. The hematological findings of the cows that were previously 
treated with DMS, proposed that the procedure was successful in causing 
immunosuppression. Severe neutrophilia was caused by corticoid due to impairment of 
adhesion molecules of neutrophils that retains the neutrophils in circulating blood (Paes et 
al., 2009; Rehfeld et al., 2013). Second reason of lymphopenia might be due to corticosteroid 
action as they cause redistribution of T-lymphocytes and lympholysis (Cohen, 1991). They 
also directly hinder lymphocyte proliferation and activation by inhibiting IL-2 and IL-2 
receptor production, and indirectly reducing synthesis of lymphocyte IL-2 by decreased 
synthesis of monocyte IL-1 (Ross et al., 1990). In experimental production of BV in cow, 
reduced milk production might be because of inhibition of lactogenesis caused by the DMS 
(Greco and Stabenfeldt, 2002; Rehfeld et al., 2013). 
2.18. Experimental pathogenesis 
 In a number of animal species BPXV transmissibility was studied experimentally that 
showed a broader host range, viz. cows, buffaloes at high virus dose, suckling mice (Swiss 
white strains and BALB/c) and guinea pigs (Singh et al., 1996). Adult mice (Swiss white and 
BALB/c), goat, sheep, and fowl showed refractory behavior to experimental infection with 
BPXV. However, when infection was given with BPH-80 strain, it produced lesions of pox 
in buffaloes and cow calves, chicken, 6-weekold mice and rabbits (Kumar et al., 1987). 
2.18.1. Buffalo calves 
 When BPXV was inoculated by the intradermal (I/D) route to buffalo calves, they 
showed lesions restricted to skin and increase in temperature at 12-DPI (Tantawi et al., 
1976). When inoculation was done in buffaloes with BPXV and CPXV they showed that 
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larger lesions were produced by BPXV as compared with CPXV and period was shorter for 
BPX (Tantawi et al., 1979a, b). The BPXV, CPXV and VACV produced only localized 
lesions on the udder and teats lacking generalization, when inoculated in lactating buffaloes. 
Upon challenge, they demonstrated complete protection between BPXV and CPXV. The 
control (in-contact) buffaloes did not show lesions of pock though a rise in body temperature 
was observed (Iwad et al., 1981). Similarly, typical skin lesions along with diarrhea and nasal 
discharge were produced by BP4 strain of BPXV when it was inoculated in buffalo calves 
via I/D route (Rana et al., 1985). Disease lasted 13-15 days and virus might be recovered 
from 5 to 9-DPI from internal organs and at 10-DPI from the skin.  
2.18.2. Rabbits 
 Rabbits developed cutaneous lesions of pock on the skin and on liver numerous small 
necrotic spots on-day-four when 0.3 ml of a 10% (w/v) BPXV infected CAM suspension was 
inoculated by intravenous route without producing any gross lesions in the internal organs 
including heart, mesenteric lymph nodes, spleen, lungs, kidney and brain. In these organs, 
presence of virus was confirmed via inoculation of tissue suspensions in rabbit skin 
(Srinivasappa and Garg, 1976). When rabbits were inoculated with BPXV via I/D route, the 
virus indicated an eclipse period of 12 h. In the skin, the virus was detected at 15 hour (hr)-
post-infection (hpi), by 36-hpi in the regional lymph nodes and primary viremia at 48-hpi. 
After an incubation period of 48 to 72-hpi, typical lesions of pox were observed on the skin, 
at primary inoculation site. The virus was initially detected on day 4 in lungs, and on day 5 in 
spleen and liver, and secondary viremia was established when virus was released from these 
organs, followed by spread of virus in gonads, intestine, stomach and kidneys between 7 and 
14-DPI (Chandra et al., 1985). After day 5 pi, on the internal organs, gross lesions included 
diffuse or focal necrotic areas on spleen, liver and lungs. Day 7 onwards, individual lesions 
appeared on the skin, uterus, intestine and in the stomach, measuring approximately 2 mm in 
diameter. Histopathological alterations include intrabronchial and intra-alveolar 
hemorrhages, and in the liver degenerative fatty changes. In recovery period there is 
multinuclear syncytial cell formation (Chandra et al., 1986a).  
2.19. Molecular diagnosis 
 The conventional methods for isolation of BPXV comprise either inoculation of 
specific hosts- cattle/buffaloes or passaging in CAM. A variety of serological assays has been 
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developed for BPX diagnosis like ELISA, SNT, counter-immunoelectrophoresis (CIE), 
AGID and immunoperoxidase test (IPT). Because of cross-reactivity among the antigens 
these methods fail in accurate BPX diagnosis. Additionally, these serological and 
conventional biological tests have limits in differentiation and identification of OPXVs. The 
SDS-PAGE analysis of virion enabled differentiation between genus and species however, it 
is not applicable to see difference between closely associated members of the same genus 
(Arita and Tagaya, 1977; Esposito et al., 1977). On the other hand, establishment of RE–
DNA profile methodology (Esposito and Knight, 1985) is the best technique for 
identification of poxvirus; however, there is a need to propagate virus and isolation of its 
genomic DNA that is time-consuming as well.  Assays based on PCR of HA and inclusion 
genes have been used for diagnosis and differentiation of OPXVs including MPXV, VACV, 
VARV and CPXV (Knight et al., 1995; Ropp et al., 1995; Meyer et al., 1997, Damaso et al., 
2000). Primers CoPV-3 and CoPV-4 using PCR methodology have been employed for 
OPXVs diagnosis like MPXV, CPXV, raccoonpox virus (RCNV), CMLV, VACV 
(Funahashi et al., 1988; Meyer and Rziha, 1993) and BPXV (Singh et al., 2006a). Full-length 
amplification of A type inclusion gene by CoPV-1 and CoPV-2 primer sets is helpful in 
OPXVs differentiation (Funahashi et al., 1988). These primers amplify 3.7 kb fragment in 
CPXV, 3.2 kb in BPXV and 2.8 kb in CMLV. The inclusion gene of BPXV genomic DNA is 
restricted in two fragments of HindIII digest (Kolte, 1998). ATI-up and ATI-low primer pair 
amplifying a fragment of inclusion gene is also used for OPXVs differentiation (Meyer et al., 
1997). Sizes of the amplicons in BPXV, VACV-WR strain, CPXV-Brighton strain and 
CMLV CP-1 strain are 1587 bp, 1603 bp, 1673 bp and 880 bp, respectively (Meyer et al., 
1997). For differentiation of CMLV from BPXV, DNA amplification fingerprinting (DAF) 
by RAPD-PCR, using viral genomic DNA has been employed. Profiles of CMLV and BPXV 
were obviously dissimilar by DAF. Differentiation of CMLV, BPXV and among different 
BPXV isolates is also feasible by DAF using full-length sequences of inclusion gene (3.2 kb) 
of these viruses as template. CMLV and BPXV were fairly dissimilar on the basis of DAF 
profiles. Likewise, DAF profiles of closely associated BPXV isolates were also different. 
Four random primers were used in these studies, one of these primers amplified >2.2 kb 
fragment in CMLV representing that DAF be able to develop virus-specific PCR. Moreover, 
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for exact diagnosis of the virus, probes and primers may be constructed using sequences of 
CMLV-specific fragment (Singh et al., 2007). 
2.20. Vaccines for pox diseases 
 Although Vero and BHK21 cells have been used for adaptation of BPXV (Chandra et 
al., 1986b; Mathew and Mathew, 1986) however, in preliminary isolation of BPXV their 
sensitivity was not reported earlier. In an experiment, the virus titer range of Vero cells was 
between log 101.0 and log 102.2 and in BHK21 cells it was found in the range of log 102.5 
to log 102.5. Mean titers for Vero and BHK21 were log 101.76 and log 103.4, respectively. 
From these results, it is apparent that both BHK21 and Vero cells might be utilized for 
isolation of BPXV if scab suspension is used. However, in the preliminary BPXV isolation, 
BHK21 cells were found to be more sensitive than Vero cells (Manoharan et al., 2009). 
Mohanty and Rai (1989) demonstrated that the Vero cell culture adapted BPXV was found to 
be completely attenuated at 40th passage for rabbits and buffaloes. It induced high level of 
humoral and cell mediated immune response in rabbits as well as in buffaloes. Study 
conducted in recent years suggests a potential possibility of reemergence of future VARV, 
posing a great threat to mankind. There is dire need to develop new but safe smallpox 
vaccines, designing of drugs against smallpox, and to control zoonotic human OPX 
infections (Shchelkunov, 2011). In a recent study, TaqMan real time PCRs (rt-PCR) and 
SYBR Green based on the C18L gene of BPXV and CMLV were employed for evaluation of 
potency of live attenuated BPXV and CMLV vaccines. The results showed that the titres 
expected by rt-PCRs were similar to that of conventional TCID50 method. The rt PCR 
method was found relatively more rapid, specific and sensitive than end point dilution 
method. Therefore, they possibly are used as supplementary tools for estimation of live 
BPXV and CMLV particles in their respective vaccines (Prabhu et al., 2012). Inspite of 
paramount success of VACV as vaccine, a number of complications have been recorded, 
differently depending on strain of the vaccine (Mercer et al., 2007; CDC, 2008). Severe 
issues observed, e.g. progressive vaccinia, occasionally neurological disorders (encephalitis), 
vaccinia eczematum, generalized vaccinia, ocular complications or myocarditis. Several 
strains are present that differ in their virulence and biological properties in animal and human 
models (Mercer et al., 2007). There is a threat that smallpox could be used as bioterrorist 
attack, however, VACV remains are also a focus of the public as vaccine against poxviruses. 
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A number of countries have obtained stocks of 1st and 2nd generation vaccines of VACV. 
Now, a highly attenuated strain of VACV i.e. modiﬁed VACV Ankara (MVA) that was 
developed by more than 500 passages in the 1970s (Mayr et al., 1978), is regarded as a safe 
vaccine to date. It is so-called 3rd generation vaccine against smallpox. It also lacks any side 
effects as compared with existing vaccines (Drexler et al., 2004; Gomez et al., 2008).  
2.21. Poxvirus vaccines; a vector for other vaccine antigen delivering 
 All candidate vaccines for use in humans must undergo preclinical testing, usually in 
animal models. However, conclusive evaluation of protective capacity in animals crucially 
relies on representative animal models for a given target disease (Sutter et al., 1994). 
Modiﬁed VACV Ankara (MVA) is a tissue culture passaged, highly attenuated strain of 
VACV that exhibits defective replication in mammalian cells. In 1960s it was developed as a 
safest candidate virus against smallpox immunization. Now, in the development of 
experimental vaccines, against cancer and other important infectious diseases, MVA is 
extensively used. Large-scale production and versatile technologies of genetic engineering, 
and quality control made possible, the Research and Development of recombinant and non-
recombinant vaccines like MVA, fulfilling today’s demands for new biomedical products. 
These vaccines give very promising results in delivering different antigens from pathogens 
against which no vaccine at all or less effective vaccine is available, e.g. chikungunya virus, 
zoonotic OPXVs, West Nile virus, highly pathogenic inﬂuenza viruses (Volz and Sutter, 
2013). 
2.22. Evolution of poxvirus virulence 
 Viruses can have intricate relationships with their hosts that can lead to the co-
evolution of virus and host genes, which can inﬂuence the virulence and transmissibility of 
the viruses. Evolution of virulence for a certain host is probably inﬂuenced by the 
effectiveness and route of transmission of the virus, the immune status of host species, the 
availability of additional reservoir hosts, intra- and inter-species competition with other 
viruses and the positive selection for hosts that are more resistant to virus infection. One of 
the best-studied examples of virus-host co-evolution is Myxoma virus (MYXV) infection of 
European rabbits in Australia and Europe. In these examples the case fatality rate (CFR) 
dropped from near 100% initially, to below 50%. The drop in CFR correlated with a longer 
survival time of the infected rabbits, which probably allowed for a more efficient and 
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prolonged transmission of the virus. The milder courses of MYXV infection over time were 
due to both the attenuation of the MYXV as well as increased resistance of the host (Kerr, 
2012). The situation is different for Squirrelpox virus (SQPV) in Great Britain. There SQPV 
causes little harm to the natural host (grey squirrel; invasive species), in which SQPV causes 
little harm, but is highly lethal in the new host (red squirrel; native species). This scenario 
might not put selective pressure on the virus to attenuate, because viruses can be transmitted 
through the natural host. It is possible that red squirrels will evolve partial resistance against 
SQPV over time, but the strong inter-species competition for resources with the grey squirrel 
might not allow for high enough population sizes or enough time for resistance to evolve.  
 It is interesting that MYXV infection of the natural Sylvilagus rabbit hosts results 
usually in mild disease, whereas infection of European rabbits is highly lethal. MYXV is 
highly pathogenic and causes myxomatosis in the European rabbit (O. cuniculus) with 
lethality rates approaching 100% (Kerr, 2012). In contrast,  RFV,  which  causes  a  mild  
disease  in  its  natural  host Sylvilagus ﬂoridanus, only causes mild disease in European 
rabbits. It is noteworthy that both MYXV and RFV infect closely related Sylvilagus species, 
and probably coevolved with their hosts, but display striking differences in their virulence for 
European rabbits (Barrett and McFadden, 2007). 
 The example of differential sensitivity of European rabbits to the closely related 
MYXV (very severe infection) and Rabbit ﬁbroma virus (RFV) (mild infection), which both 
cause mild infection in their natural Sylvilagus specie hosts highlights that the establishment 
of infection in other species is inﬂuenced in part by chance and may be hard to predict 
without detailed molecular knowledge about host-virus interactions. Another striking 
example where a host switch between related species results in markedly increased virulence 
is SQPV. SQPV appears largely avirulent for its presumptive host Sciurus carolinensis but is 
highly virulent for Sciurus vulgaris and probably contributes to the demise of this species in 
the United Kingdom (Rushton et al., 2006). In general, it appears that transfer between 
relatively closely related species as seen for MYXV and SQPV hosts, can cause more severe 
disease, whereas virus transfer between more distantly related species, might result in 
relatively less disease severity and/or transmissibility (Haller et al., 2014). The molecular 
basis for the high virulence of VARV to humans, the human-speciﬁcity and the attenuation 
of some VARV strains is not directly apparent from sequence comparisons (Esposito et al., 
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2006). Similarly, the molecular mechanisms responsible for the high MYXV virulence in 
European rabbits as opposed to in American rabbits as well as for the attenuation of MYXV 
ﬁeld strains are unsatisfactorily understood, despite the availability of whole genome 
sequences of many MYXV isolates (Kerr et al., 2012). These findings have interesting 
implications for the evolution of poxvirus host range and virulence genes. After initial host 
changes, copy number of genes that are sub-optimally adapted for their new hosts, might 
initially expand and increase their chance of acquiring beneficial mutations for replication in 
their new host. After acquisition of such mutations, the copy number might collapse. 
Additional copies might be retained if additional mutations evolve that provide a selective 
advantage for the virus, e.g. by targeting a different host protein or if the virus cycles in 
different hosts (Haller et al., 2014; Liu et al., 2012). In brief, re-emergence of OPXV 
including BPXV is a real danger and contingency planning is needed to define prophylactic 
and therapeutic strategies to prevent or stop an epidemic (Gurav et al., 2011). 
2.23. Eminent poxvirus threats 
 Poxviruses face stiff inter-species competition. Because VARV was so prevalent in 
human populations and smallpox survivors gained immunity against other OPXVs, the latter 
likely never had a chance to establish themselves in the human population. However, with 
the eradication of VARV from nature and the cessation of mass vaccinations with VACV, we 
are left vulnerable to infection by other OPXVs. One major threat would be the emergence of 
a human-adapted MPXV with increased virulence and/or human-to-human transmission 
while at the same time retaining its ability to infect multiple animal species. The control of 
such a virus would pose a major challenge. Other threats to humans are CPXVs, which have 
a very broad host range and repeatedly cause infections in humans. Because CPXVs contain 
the largest sets of immunoregulatory and host range genes of all OPXVs, the ability of 
CPXVs to evolve into a more virulent pathogen might be especially high. Moreover, the high 
recombinogenic potential of poxviruses makes the emergence of hybrid poxviruses possible 
that have increased virulence and/or host ranges possible (Bratke et al., 2013). Because 
genetic manipulation of poxviruses is relatively easy and because of advancements in gene 
synthesis, another danger is the accidental or deliberate release of poxviruses with increased 
virulence and host range or viruses that might cause disease even in immunized 
people/animals. Another concern is the release of viruses, such as VARV, that were 
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developed as bio-weapons (Barrett and McFadden, 2007; McFadden, 2010; Shoham and 
Wolfson, 2004). 
2.24. Assessment of the threat of OPXV-related diseases 
 Medical countermeasures to OPXVs are important because smallpox re-emergence 
through a release of VARV would be a high-consequence event (although the risk of this 
happening is perceived to be low), and because emerging and re-emerging zoonotic OPXV- 
associated diseases continue to be a public health issue. The WHO commission to certify 
smallpox eradication instituted an international surveillance program for smallpox-like 
diseases in 1971 (Breman and Arita, 1980), which ultimately resulted in an increased 
awareness of human MPXV infection (Breman et al., 1980).  Inspite of that, today, MPXV 
infections are on the rise in the Democratic Republic of the Congo (DRC) (Rimoin et al., 
2010), and outbreaks in Sudan and the United States indicate the potential for MPXV to 
spread (Reynolds et al., 2012). Other OPXV infection outbreaks are routinely observed and 
include VACV in Brazil (Megid et al., 2012), CPXV in Europe (Vogel et al., 2012), and 
BPX in India (Gurav et al., 2011). Current research also indicates that OPXV in wildlife 
reservoirs is more prevalent than previously thought (Salzer et al., 2013; Gallardo-Romero et 
al., 2012; Mota et al., 2010). Long-held concerns regarding the threat of smallpox as a 
weapon of bioterrorism increased after the events of September 11, 2001 and the subsequent 
anthrax releases (Tucker, 2011). Combined, these conditions make the development of 
medical countermeasures against OPXV-associated disease an ongoing and current research 
effort. Worldwide, immunization against smallpox ceased in 1980. Adverse event rate related 
with the present licensed live VACV vaccines create restoration of policies proposing routine 
prophylactic vaccination unlikely in the absence of OPXV outbreaks. As a result, licensing of 
therapeutics and safe vaccines that may be used post-OPXV exposure is needed to protect the 
worldwide population from these attacks (Keckler et al., 2013). 
2.25. Diagnosis of pox viruses 
 The ﬁrst-line and classical tool to diagnose poxviruses in biopsies or swabs is electron 
microscopy: viral particles are generally observed in sufficient quantity with their 
characteristic morphology. Now-a-days, for rapid identification and differentiation of 
poxviruses up to species level, conventional PCR, real-time PCR and sequencing are the 
methods of choice (Mercer et al., 2007). For further characterization, these viruses can easily 
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be isolated in different cell culture systems. Infection can be demonstrated in histological 
sections by hyperplasia of epithelium. Presence of intracytoplasmic large eosinophilic A-type 
inclusion bodies (ATI) is a pathognomic feature of poxviruses. Serological assays like, 
neutralization test is used for diagnosing retrospective infections. However, suspicious cases 
of CPXV, MPXV and VACV infections cannot be confirmed alone on the basis of their 
clinical presentations. In-charge of the laboratory should be expert enough in the mentioned 
techniques to give a confirmatory diagnosis of poxviruses. 
2.26. Differential diagnoses 
 Parapoxviruses (PPVs) are widespread pathogens that can infect a variety of different 
mammals including humans. Prototypic members of this genus are Orf virus (ORFV), 
Bovine papular stomatitis virus (BPSV) and Pseudocowpoxvirus (PCPV), the genomes of 
which have been completely sequenced and contain 134 to 140 kb (four ORFV strains), 134 
kb and 135-145 kb (PCPV), respectively (Delhon et al., 2004; Hautaniemi et al., 2010). In 
phylogenetic analyses, PPVs form a sister-clade to OPXVs and clade-II poxviruses (Bratke 
and McLysaght, 2008; Bratke et al., 2013). Parapoxviruses genomes are GC rich (>60%), a 
feature shared with Molluscum contagiosum virus and Crocodilepox virus (Lefkowitz et al., 
2006). Parapoxviruses are thought to establish infection after entry through small skin lesions 
and infection is usually restricted to the epidermis and oral mucosa (Fleming and Mercer, 
2007). ORFV causes serious infections in sheep and goats worldwide and poses a significant 
economic burden. Other animals that can be infected include camels, musk ox, cats, reindeer 
and humans. Interestingly, ORFV can reinfect its host, although reinfection usually results in 
milder pathogenicity (Fleming and Mercer, 2007; Hosamani et al., 2009). BPSV and PCPV 
cause skin diseases in cattle worldwide, but usually induce milder diseases than ORFV in 
sheep and goats. Transmission of BPSV and PCPV from cattle to humans can also occur 
(Fleming and Mercer, 2007; Hosamani et al., 2009). ORFV, BPSV and PCPV cause 
indistinguishable skin infections, known as Milker’s nodules, in humans that have had close 
contact with infected animals. Lesions are generally localized and resolve after 4-6 weeks. 
However, serious complications can occur, such as the development of large tumor-like 
lesions and erythema multiform, especially in immunodeficient individuals. Remarkably, 
immunity against PPV infections in humans appears to be incomplete, as reinfections can 
occur (Fleming and Mercer, 2007). Occupational risk of infections with poxviruses has been 
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observed, e.g. for animal traders (MPXV), cow workers (PPV), animal keepers (MPXV, 
CPXV) and health care workers (VACV),  (Juncker-Voss et al., 2004; Croft et al., 2007; 
Reynolds et al., 2007; Trindade et al., 2007; Kurth et al., 2008). 
2.27. Prophylaxis and control 
 The first line response to OPXV disease is through vaccination with ﬁrst-generation 
and second-generation vaccines, such as Dryvax and ACAM2000. Although these vaccines 
provide excellent protection, their widespread use is impeded by the high level of adverse 
events associated with vaccination using live, attenuated virus. It is possible that vaccines 
could be used in combination with antiviral drugs to reduce the incidence and severity of 
vaccine-associated adverse events, or as a preventive in individuals with uncertain exposure 
status or contraindication to vaccination. These studies suggest that, in the setting of post-
exposure prophylaxis against pox diseases, co-administration of brincidofovir (BCV 
CMX001) with vaccination should be considered a first response in subjects of uncertain 
exposure status or as a means of reduction of the incidence and severity of vaccine-associated 
adverse events (Parker et al., 2014). However, before and after milking, dipping of teats in 
antiseptic solutions, helps in prevention of diseases, like mastitis and herpetic mamilite 
(Almeida et al., 2008), BV and pseudocowpox (de-Oliveira et al., 2011). 
2.28. Strategic importance 
 Our neighboring country, India, like most other countries in the world, has of late 
been vulnerable to Chemical, Biological, Radiological and Nuclear (CBRN) threat, on 
account of its unique geographic position. Biological threat is an imminent threat in the 
hands of a terrorist (Anonymous, 2001; Kumar, 2001), and Pakistan being the neighbouring 
country is facing same risk due to its borders and geographical situation. The public health 
system of our country is overburdened due to its present role and bio-attack response is not a 
priority area. As the prime focus is on the CR and N threats in the integrated CBRN 
awareness strategy and that specialized and technical forces are needed to deal with a bio-
threat; hence there is a need for a standard shift in policy (Jindal et al., 2014). It is highly 
unlikely to be an option in war as the country using it will fear that its own troops might get 
affected. However, the risk of a terrorist organization using it is very real (Sharma, 2001). 
His capability to acquire, cultivate and disseminate pathogens is widespread. Well 
documented bio-agent attacks are present in the past, like the Salmonella released in salads in 
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a restaurant of Oregon, USA (Torok et al., 1997), and anthrax spores filled letters of 2001, 
which resulted in the death of five persons in USA (Kournikakis et al., 2011). Biological 
weapons are potentially more lethal than thermonuclear warheads (Carus, 1998). WHO has 
estimated that “50 Kg of anthrax spores released over a city of half million people would kill 
95,000 and incapacitate 125,000” (Anonymous, 1970). These predictions are based on a non-
contagious agent. With use of a contagious agent, like small pox, the disease could spread to 
several areas in a matter of hours and would become a worldwide pandemic within days, due 
to the mobility of our societies (Bhardwaj et al., 2009).  
2.29. Conclusion 
Current knowledge is insufficient to predict the outcomes of poxvirus host-switches. 
Every animal or human that comes into contact with poxvirus-infected animals or arthropod 
vectors of poxviruses is at risk for productive infection. Whether productive infection can be 
established depends on the effective manipulation of the host immune response by the 
querying virus. It is likely that both gene loss and the acquisition of new genes, through gene 
duplication, recombination, horizontal transfer, and sequence and expression differences in 
viral proteins, as well as species-specific interactions with host proteins play prominent roles 
in determining virus host range. The availability of so much new poxvirus genomic sequence 
information is providing a treasure for future research on host-virus interaction that will lead 
to a better understanding of virus host range. Much research on poxvirus host range genes 
has been performed in heterologous systems that do not represent natural host-virus 
relationships or with viruses without a well-defined host range. Detailed analyses of natural 
host-virus interactions, facilitated through technological advances and the development of 
new assay systems, will extend our knowledge about this important subject and will provide 
us with valuable information for risk assessment of possible threats and management of 
newly emerging viruses. 
Very little work has been done on BPXV in Pakistan so far. Keeping in view the 
research gap, there was a need to have a comprehensive study on BPX. Therefore, we 
hypothesized that; scab producing diseases in buffaloes are mostly due to BPXV, lesions in 
this disease are similar to VACV infections, disease has specific effect on blood parameters, 
there are different pre-disposing factors in disease progression and attenuated field virus can 
be used safely for vaccine preparation. 
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CHAPTER 3 
MATERIALS AND METHODS 
3.1. Study period, sampling and study setting 
 Study period span over more than two years (November-2012 to December-2014) for 
sampling, processing and collection of data from 96 BPX suspected herds having a total of 
975 buffaloes, along with collection of blood samples (n=163) and scab samples (n=19) from 
clinical cases of this disease. Sample size was calculated using formula below (Thrusfield, 
2007). 
n=1.962 Pexp(1- Pexp)/d2  
Where:  
n= required sample size 
Pexp = expected prevalence 
d= desired absolute precision 
 Scab samples and blood samples (4-5 mL from the jugular vein in EDTA coated 
tubes) were collected aseptically from BPX suspected animals from different areas of Punjab 
densely populated with buffaloes including Lahore, Faisalabad, Bureywala (Vehari), 
Rawalpindi, Attock, Okara, Sheikhupura, Nankana Sahab, Sialkot, Gujranwala, Gujrat and 
DG Khan after continuous contact with fellow veterinarians and case complaints recorded at 
Veterinary Research Institute, Lahore Disease Diagnostic Section. These samples were 
brought to the department of Pathology for processing. 
3.2. Epidemiological studies 
Data were collected on the parameters enlisted below to study the association of 
different factors in disease progression. 
a. Milkers suffering from fever 
b. Milkers exhibiting lesions 
c. Milking from multiple persons 
d. Reluctance of animals in milking 
e. Rearing multiple species of animals in the same herd 
f. Addition of young buffaloes 
g. Septic condition in animals 
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h.  Decreased milk production 
i. Total number of animals in a herd 
j. Age of animals 
k. Type of housing  
l. Type of herds 
3.3. Hematological studies 
 Hematological changes including total erythrocyte count (TEC), hemoglobin 
concentration (Hb conc.), packed cell volume (PCV), total leukocyte count (TLC) and 
differential leukocyte count (DLC) were determined in apparently healthy and diseased 
animals (Benjamin, 1978). 
3.4. Identification of virus through PCR 
3.4.1. Synthetic oligonucleotide primers 
The oligonucleotide primers for PCR amplification, BPXV-C18L-F/BPXV-C18L-R, 
designed from C18L gene of viral genome were synthesized commercially by using protocol 
described earlier (Singh et al., 2008) along with 100 bp DNA ladder, with modification in 
DNA extraction methodology and annealing temperature to optimize PCR conditions in local 
laboratory setup. To visualize the amplicons, resulted products after staining with ethidium 
bromide were analyzed on 1.5% agarose gel after electrophoresis. 
The oligonucleotide primer pair used for PCR diagnosis of BPXV was; 
BPXV-C18L-F = CGG TTA TTG GAA TAT GGA GCG AGTG (25 bases) 
BPXV-C18L-R = CGT AGT AAT CGT CGT AGG GAG AGAC (25 bases) 
3.4.2. DNA extraction 
Scab samples were triturated in PBS (pH 7.4) and suspension of 10% (w/v) was 
prepared for genomic DNA extraction. Material was centrifuged at 2000 rpm for 3 minutes 
and supernatant was used directly in PCR reaction as template (new methodology adopted in 
the present research). Remaining standard procedure has been described  by Singh et al. 
(2008).  
3.4.3. Polymerase chain reaction 
Polymerase chain reaction was carried out in a 50 µl reaction volume using Techne 
Touchgene Gradient PCR Thermal Cycler (Bibby Scientific Limited, UK). Two micro litres 
of supernatant containing suspected viral material was added to 48µl of PCR reaction 
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mixture consisting of: 35µl DD-water; 5µl, 10XPCR buffer; 5µl MgCl2 (25mM), 0.2µl Taq 
DNA polymerase (5U/µl), 1µl dNTP mix (10mM each), 1µl forward primer (25 p moles/µl), 
and 1µl reverse primer (25 p moles/µl). Pair of PCR primers was evaluated on NCBI Gene 
Bank, Accession No. EF205284.1 using ‘Primer Select’ program of ‘Lasergene’ software 
(DNASTAR Inc. Madison, WI, USA). Initially, gradient temperature approach was 
employed to find out most suitable annealing temperature. Finally 53°C was chosen as 
annealing temperature for routine PCR. Cycling profile used for PCR reaction was as 
follows: 94°C for 5 min, 1 cycle; 94°C for 30 sec, 53°C for 30 sec, 72°C for 30 sec, 30 
cycles; 72°C for10 min, 1 cycle. 
3.5. Preparation of vaccine 
3.5.1. Subculturing cell cultures 
Protocols for cell culturing, infection and harvesting as laid down by FAO were 
followed (Anonymous, 1994). For monolayer preparation serially cultivated established 
cultures of Vero cells were used having their original morphology. For long term storage 
Vero cells were stored at -196oC in liquid nitrogen where as for short term they were stored 
at -80oC in ultra low freezer. Before use the Vero cells were removed from freezing condition 
and dispensed into tissue culture flask containing Glasgow's minimal essential medium 
(GMEM) and fetal bovine serum (FBS), incubated at 37oC with 5% CO2 tension till the 
appearance of complete monolayer. 
3.5.1.1. Procedure 
i. Exhausted medium was discarded from tissue culture flask having complete 
monolayer. 
ii. Warm (37oC) PBS-prewash (5ml/25 sq-cm) was added to the side of the flask 
opposite the cells, so as to avoid dislodging cells. After rinsing, the medium was 
discarded. This step was necessary to remove traces of serum which would inhibit the 
action of the trypsin. 
iii. Trypsin/EDTA solution (3ml/25 sq-cm) was to the side of the flask opposite the cells. 
Turned the flask over to cover the monolayer completely. Left for 30 second and 
discarded the trypsin/EDTA, making sure that the monolayer was not detached. Using 
trypsin/EDTA at 4oC helped to prevent this. 
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iv. Returned the bottle to 37oC and incubated until cells rounded up; when the bottle was 
tilted, the monolayer slide down the surface (this usually occurred after 5-15 min).  
v. Pre-warmed growth medium (0.1-0.2 ml/sq-cm) was added and dispersed cells by 
repeated pipetting over the surface bearing the monolayer. Finally, pipette the cell 
suspension up and down a few minutes, with the tip of the pipette resting on the 
bottom corner of the bottle. Pipette up and down sufficiently to disperse the cells into 
a single cell suspension. 
Note: The degree of pipetting required varies from one culture to another; some disperse 
easily, others require vigorous pipetting. Almost all incur mechanical damage from shearing 
forces if pipetting too vigorously. A single cell suspension is desirable at subculture to ensure 
an accurate cell count and uniform growth on reseeding. If the cells are not disaggregated, 
the new culture will contain numerous micro-colonies that cause problem in the culture. 
vi. Cells were counted by haemocytometer  
vii. Cell suspension was seeded in clean, sterile tissue culture flask. 
3.5.2. Determination of viable cell count 
 The concentration of cell suspension was determined by counting the cells in a 
haemocytometer. To differentiate between live and dead cells in suspensions, the most 
widely used procedure i.e. dye exclusion test was used. This method is based on the 
assumption that certain dyes e.g. trypan blue, methylene blue, acridine orange, eosin, 
nigrosin, safranine etc. stain only dead cells while live cells remain unstained when exposed 
to these substances in suspensions. Among the different vital dyes, the most frequently 
employed is trypan blue. 
3.5.2.1. Procedure 
i. Slide was prepared as: (a) Surface of the slide was clean with 70% alcohol taking care 
not to scratch the semi-silvered surface. (b) Cover slip was cleaned and pressed down 
over the grooves and counting area. The appearance of interference patterns 
(“Newton’s rings-rainbow colours between cover slip and slide) indicated that the 
coverslip was properly attached. 
ii. Sample was mixed thoroughly, and 0.5 ml of cell suspension was added to 4.5 ml of 
trypan blue stock solution. 
iii. Mixed and allowed to stand for 10 minutes at room temperature. 
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iv. Mixed the sample thoroughly again and collected 20uL into the tip of a micropipette. 
v. Transferred the cell suspension immediately to the edge of the haemocytometer 
chamber and let the suspension run out of the pipette and drew under the coverslip by 
capillary. Precaution was adopted not to overfill or underfill the chamber; the fluid 
was allowed to run to the edge of the grooves only.  
vi. Blotted off surplus fluid (without drawing from under the coverslip) and transferred 
the slide to the microscope stage. 
vii. Objective lens of power 10X was selected and focused on grid lines in chamber. 
When focusing was difficult because of poor contrast, it was set one or more of the 
followings; field iris was close down, made the lighting slightly oblique by tilting the 
mirror or offsetting the condenser. 
viii. Slide was moved so that the field was in the central area of the grid. Each chamber 
was divided into 9 large squares by three parallel lines. This area was 1sq.mm. Using 
a standard 10x objective it almost filled the field. 
ix. Stained and unstained cells were counted in large centre square and in the four corner 
squares. Cells which lay on the top and left-hand lines of each square were counted, 
and those on the bottom or right-hand lines were excluded to avoid counting the same 
cell twice. 
3.5.2.2. Analysis 
i. Each chamber of a Neubauer type haemocytometer was divided into 9 large squares, 
each side of which was 1mm long. The cover glass was supported 0.1 mm over the 
haemocytometer. Thus, when properly filled, the fluid volume in any one large square 
was 1mm x 1mm x 0.1mm or 0.1 mm3. Since 0.1 mm3 = 10-4 cm3, the multiplier was 
10000 (conversion factor [CF]). 
The counts could be misleading when the sample was not a true aliquot or when the 
cells were not randomly distributed in the haemocytometer. To avoid this, cell 
suspension was diluted such that there were no more than 40 cells per square. When 
the count between sides differed by more than 20%, a second sample was counted. 
ii. To calculate the total number of cells, following formula was used; 
Total number of cells per ml (N) = Total cell count x dilution factor x CF 
    Number of squares counted 
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iii. To calculate the percentage of dead cells, following formula was used; 
Percentage of dead cells in sample = No. of stained cells x 100 
     Total No. of cells counted 
iv. To calculate the percentage of live cells, following formula was used; 
 
Percentage of live cells in sample = No. of un-stained cells x 100 
     Total No. of cells counted 
3.5.3. Dilution of cells for dispensing in flasks  
Cells were diluted to the seeding concentration of 2-3x105 cells/ml by diluting the 
cells in warm (37oC) growth medium and distributed that among flasks. Cap the flasks and 
returned to the incubator at 37oC. Check after about 1 hour for pH change. When sometimes 
pH rose in a medium, it was returned to aseptic area and culture was gassed (1-2 seconds) 
with 5% CO2. To feed or harvest medium, flasks were taken to sterile work area and 
discarded the medium as usual and replaced with fresh medium.  
3.5.4. Infection and attenuation of filed virus on cell line 
Vero cells were grown in 75cm2 tissue culture ﬂasks up to 90% conﬂuency using 
GMEM having 10% FBS. When 90% cell growth was observed, the spent medium was 
discarded and the cells were infected with PCR-positive scab samples. The cells were 
incubated for 1 hr at 37oC with intermittent shaking at an interval of 15 min to enable the 
adsorption of the inoculum. After incubation, the inoculum was discarded; the cells were 
washed twice with sterile PBS, fed with maintenance medium (2% minimum essential 
medium; FBS) and returned to incubator. The cultures were observed daily under an inverted 
microscope for CPEs. When 75% or more cells showed the CPEs then viral material was 
harvested by means of freezing and thawing repeatedly. After aliquoting, the supernatant was 
stored in ultra low freezer at -70oC until use (Gurav et al., 2011). This procedure was 
repeated until complete attenuation and adaptation of field isolate on Vero cells was done. 
Attenuation status of the virus was assessed in the rabbits at each passage by I/D inoculation 
to determine its degree of infectivity (Mohanty and Rai, 1989).  
3.6. Sterility test 
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The wet material was subjected to sterility test by inoculating 0.1 mL of viral 
suspension in nutrient broth, nutrient agar, MacConkey’s agar, blood agar and Sabouraud’s 
agar. Media was incubated at 37oC and growth if any, was checked daily for 2 days. 
3.7. Safety test 
Five rabbits were injected via intramuscular (IM) route with 2 mL of viral suspension 
each and one rabbit was kept as negative control. After completion of incubation period of 4 
days, temperature and appearance of local reaction were recorded daily for 5 days. 
3.8. Estimation of viral contents of vaccinal material 
After successful adaptation and attenuation of field isolate of BPXV, following procedures 
were carried out; 
3.8.1. Procedure 
i. The virus content test of pooled liquid vaccine was carried out using Vero cells. 
ii. Ten-fold dilutions of vaccine material were made (5 tubes per dilution) in GMEM 
growth medium.  
iii. Virus was inoculated into the tubes immediately prior to the addition of the 
suspension of cells.  
iv. Freeze dried vaccine was reconstituted in 1 ml of GMEM growth medium. 
v. 8 bijou bottles with 4.5 ml of growth medium were kept for preparation of serial 
dilutions and marked in order. 
vi. 10-fold dilution of viral material was prepared from 10-1 to 10-8  
vii. Pipette 0.5 ml of the liquid vaccine, marked as 10-1  
viii. The pipette was discarded. With a fresh pipette contents of this bottle were mixed 
thoroughly and 0.5 ml was transferred to the second bottle, marked as 10-2  
ix. The mix and transfer sequence was repeated until the 10-8 dilution, each time with a 
fresh a pipette. This resulted in a set of 8 bottles containing serial dilutions of the 
vaccine from 10-1 through 10-8 
x. Virus dilutions were kept on ice throughout the inoculation process. 
3.8.2. Titration in flat bottom, tissue culture grade microplates 
i. Dispensed 0.1 ml culture medium into each of 8 wells of column 7. 
ii. Dispensed 0.1 ml of vaccine dilution 10-8 into each of 5 wells of column 1 to 7 in row 
H and continue for every dilution step towards row A (dilution 10-1). 
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iii. Added 0.1 ml of Vero cell suspension (cell concentration was adjusted to 1.0x105/ml 
after counting) to each well in column 7. 
iv. Added 0.1 ml of Vero cell suspension (cell concentration was adjusted to 1.0x105/ml 
after counting) to each row of column 1 to 5 starting from row H to row A. Column 6 
was kept empty. 
v. Sealed and incubated the plates in 5% CO2 atmosphere at 37oC for 10-11 days. 
vi. Using an inverted microscope at objective power 10x, examined the monolayers for 
evidence of CPE, initially, on day 4-5 and, thereafter, on every second day until day 
10-11. Recorded wells in which the cells were showing CPE.  
vii. Cells in column 7 should be compact and devoid of CPE. 
viii. The same pipette was used to inoculate several dilutions of a series when the least-
concentrated suspension (highest dilution) was inoculated first and the most 
concentrated one last. 
ix. Extreme care was taken to ensure pipette did not touch the neck of tubes or wells 
during the dispensing of cell suspension. 
x. All operations were performed using aseptic techniques under laminar air flow. 
xi. Virus titre was calculated using the Reed and Muench (1938) method (titre/ml) 
3.9. Vaccine efficacy 
3.9.1. Calculation of median effective dose (TCID50) from wild type of virus for 
challenge dose preparation 
 Several approaches for calculating the “median effective dose” were available, 
including the Reed-Muench and Spearman-Karber methods. The Reed-Muench method was 
simple in structure and regarded as standard that’s why it was used in our calculations. 
 The most frequently used and statistically useful end-point is 50%. It is the “median 
effective dose”, which in virus infectivity titration in cell cultures is the Tissue Culture 
Infective Dose (TCID50). Thus the “median effective dose” is the dilution of the test 
population which demonstrates response in 50% of the population. i.e. CPE in 50% of a large 
number of inoculated cultures. 
3.9.1.1. Reed and Muench method to calculate 50% end-point dilution 
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 The test sample was diluted in a geometric series, that is, with a constant ratio 
between successive dilutions, and a constant volume (0.1 ml) of each dilution was inoculated 
into each of at least five replicate cell cultures. 
i. “Difference of logarithms” was calculated by the following formula: 
 50% - (percentage of infected next below 50%)  x log of dilution factor 
 (percentage of infected next above 50%) –  
 (percentage of infected next below 50%) 
ii. Log (reciprocal of 50% end-point dilution) 
 = log (reciprocal of 50% starting-point dilution) – difference of logarithms 
3.9.2. Trials in rabbits to check vaccine efficacy 
Nine rabbits were immunized with 1.0 mL of 102.5 TCID50 (calculated using method 
described by Reed-Muench) of viral suspension via I/D route. Three rabbits were kept as 
negative control (1 mL normal saline was injected via I/D route). At 21-DPI, serum was 
collected from rabbits for serum-virus neutralization assay. Rabbits were kept resting for 
relieving stress of bleeding during blood collection for serum utility. After 30 days of 
immunization, three-rabbits were challenged with 10 TCID50, three-rabbits were challenged 
with 100 TCID50 and three-rabbits were challenged with 1000 TCID50. Three rabbits from 
negative control group were also injected with respective TCID50 of virulent field isolate of 
BPXV via I/D route. Rabbits were observed daily for 7 days. The gradual change in lesions 
was observed and tissues were processed for histopathology. 
3.10. Histopathology 
 Histopathology of skin of the rabbits from control and infected groups was done as 
described by Bancroft and Gamble (2007).  
3.11. Statistical analysis 
Data on hematological parameters were analyzed by independent student t-test, 
available in SPSS software (Steel and Torrie, 1980). Data on epidemiological factors were 
evaluated by frequency analysis and logistic regression analysis. Odd’s ratios were also 
worked out by SAS software (SAS, 2003). Confidence limits (95%) were determined using 
WinPepi software (Abramson, 2011). Results on vaccine efficacy were analyzed by 
determining the preventable fraction of vaccine in control and pre-immunized groups after 
challenging them (Tizard, 2013). 
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CHAPTER 4 
RESULTS 
4.1. Epidemiology 
 During the field study, 96 herds, having a total no. of 975 buffaloes suspected for 
BPXV infection, from different locations of Punjab, were surveyed (Table 4.1). To check the 
association of different factors with BPX production, data were collected on the following 
factors; milker’s fever, milker’s skin lesions, presence of multiple species in the same herd, 
introduction of young buffaloes, total no. of animals, reluctance of animals in milking, milk 
yield, septic condition of animals, multiple person milking, type of housing, age of the 
animal and type of herd. 
4.1.1. Frequency analysis and confidence limits 
 Frequency analysis and 95% confidence limits showed that, significant effect (P < 
0.05) of milker’s fever was observed on disease production. Herds where milkers were 
suffering from fever, 76.92% pox diseased animals were found having chance of infection 
65.55 to 85.95%, and herds where milkers were not suffering from fever, 22.45% pox 
diseased animals were found having chance of infection 15.01 to 31.49% (Table 4.2).  
 Milker’s skin lesions had significant effect (P < 0.05) on disease production. Herds 
where milkers were having skin lesions were present, 78.57% pox diseased animals were 
found having chance of infection 66.41 to 87.84%, and herds where milkers were not having 
skin lesions, 26.17% pox diseased animals were found having chance of infection 18.51 to 
35.10% (Table 4.3). 
 Presence of other species in the same herd had significant effect (P < 0.05) on disease 
production. Herds where multiple species were present, 57.89% pox diseased animals were 
found having chance of infection 47.80 to 67.51%, and herds where only buffaloes were 
reared, 25% pox diseased animals were found having chance of infection 15.81 to 36.28% 
(Table 4.4). 
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Table 4.1: Number of buffalo farms visited in different areas of Punjab 
 
Area  No. of herds 
visited  
No. of animals 
Lahore  27  223 
Faisalabad  26  272 
Nankana Sb  2  26 
Rawalpindi  4  36 
Attock  5  95 
Okara  8  96 
Sheikhupura  5  49 
Bureywala  4  37 
Gujrat  5  67 
DG Khan  3  25 
Sialkot  5  38 
Gujranwala  2  11 
 Total=96  Total=975 
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Table 4.2: Effect of milker’s fever on BPXV infection in buffaloes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data subjected to chi-square test revealed significant effect (P < 0.05) of milker’s  
fever on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* DF = degree of freedom 
* P = level of significance 
Milkers suffering 
from fever  
Negative  Positive (%)  95% CI  
Fever  15  50 (76.92)  65.55-85.95  
No fever  76  22 (22.45)  15.01-31.49  
Chi-Square=46.7370, DF=1, P=<0.0001 
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Table 4.3: Effect of milker’s skin lesions on BPXV infection in buffaloes 
 
Milker’s skin lesion  Negative  Positive (%)  95% CI  
Lesion  12  44 (78.57)  66.41-87.84  
No lesion  79  28 (26.17)  18.51-35.10  
Chi-Square=40.6845, DF=1, P=<0.0001 
 
Data subjected to chi-square test revealed significant effect (P < 0.05) of milker’s  
skin lesions on BPXV infection in buffaloes.  
* BPXV = buffalopox virus  
* CI= confidence interval  
* DF = degree of freedom 
* P = level of significance 
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Table 4.4: Effect of other species on BPXV infection in buffaloes 
 
Species  Negative  Positive (%)  95% CI  
Multiple spp. 40  55 (57.89)  47.80-67.51  
Single spp.  51  17 (25)  15.81-36.28  
Chi-Square=17.2833, DF=1, P=<0.0001 
 
 
Data subjected to chi-square test revealed significant effect (P < 0.05) of multiple  
species on BPXV infection in buffaloes. 
Multiple species means presence of sheep, goat and cows in one herd. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* DF = degree of freedom 
* P = level of significance 
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 Introduction of young buffaloes in a herd had significant effect (P < 0.05) on disease 
production. Herds having history of addition of young buffaloes, 55.95% pox diseased 
animals were found having chance of infection 45.22 to 66.28%, and herds having no recent 
history of addition of young buffaloes, 31.65% pox diseased animals were found having 
chance of infection 22.12 to 42.49% (Table 4.5). 
 Number of animals in a farm had significant effect (P < 0.05) on disease production. 
Herds where total no. of animals was 14-18, maximum percentage i.e. 72.22% pox diseased 
animals were found having chance of infection 48.73 to 89.04% (Table 4.6). 
 Reluctance in milking had significant effect (P < 0.05) on diseased production. Herds 
where animals were reluctant in milking, 61.54% pox diseased animals were found having 
chance of infection 51.25 to 71.10%, and herds where animals were not reluctant in milking, 
22.22% pox diseased animals were found having chance of infection 13.75 to 32.89% (Table 
4.7). 
 Milk yield had significant effect (P < 0.05) on disease production. Herds where 
production was decreased, 64.29% pox diseased animals were found having chance of 
infection 52.58 to 74.83%, and herds where milk yield was normal, 29.03% pox diseased 
animals were found having chance of infection 20.50 to 38.85% (Table 4.8). 
 Previous history of septic condition of animals had significant effect (P < 0.05) on 
disease production. Herds where animals were exhibiting septic condition, 72.22% pox 
diseased animals were found having chance of infection 56.05 to 84.94%, and herds where 
animals were normal, 36.22% pox diseased animals were found having chance of infection 
28.21 to 44.85% (Table 4.9). 
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Table 4.5: Effect of introduction of young animals on BPXV infection in buffaloes 
 
Introduction young 
buffaloes  
Negative  Positive (%)  95% CI  
Recent addition  37  47 (55.95)  45.22-66.28  
No addition  54  25 (31.65)  22.12-42.49  
Chi-Square=9.6940, DF=1, P=0.0018 
 
 
Data subjected to chi-square test revealed significant effect (P < 0.05) of introduction 
 of young animals on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* DF = degree of freedom 
* P = level of significance 
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Table 4.6: Effect of total no. of animals on BPXV infection in buffaloes 
 
Total no. of animals  Negative  Positive (%)  95% CI  
4-8  39  26 (40)  28.65-52.22  
9-13  34  15 (30.61)  18.96-44.50  
14-18  5  13(72.22)  48.73-89.04  
19-23  3  1(25)  1.25-75.77  
24-28  3  0(0)  0.0-63.16  
>28  7  17(70.83)  50.64-86.26  
Chi-Square=6.4666, DF=1, P=0.0110 
 
Data subjected to chi-square test revealed significant effect (P < 0.05) of total no. of animals 
on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* DF = degree of freedom 
* P = level of significance 
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Table 4.7: Effect of BPXV infection on reluctance in milking in buffaloes  
 
Reluctant in milking  Negative  Positive (%)  95% CI  
Reluctant  35  56 (61.54)  51.25-71.10  
Non reluctant  56  16 (22.22)  13.75-32.89  
Chi-Square=25.0414, DF=1, P=<0.0001 
 
Data subjected to chi-square test revealed significant effect (P < 0.05) of reluctance 
 in milking on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* DF = degree of freedom 
* P = level of significance 
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Table 4.8: Effect of disease on milk yield in BPXV infection in buffaloes 
 
Milk production  Negative  Positive (%)  95% CI  
Decreased  25  45 (64.29)  52.58-74.83  
Normal  66  27 (29.03)  20.50-38.85  
Chi-Square=20.0044, DF=1, P=<0.0001 
 
Data subjected to chi-square test revealed significant effect (P < 0.05) of  
decreased milk yield on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* DF = degree of freedom 
* P = level of significance 
 
69 
 
 
Table 4.9: Effect of septic condition in animals on BPXV infection in buffaloes  
 
Septic condition 
in animals  
Negative  Positive (%)  95% CI  
Septic  10  26 (72.22)  56.05-84.94  
Normal  81  46 (36.22)  28.21-44.85  
Chi-Square=14.6519, DF=1, P=0.0001 
 
Data subjected to chi-square test revealed significant effect (P < 0.05) of  
septic condition in animals on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* DF = degree of freedom 
* P = level of significance 
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 Non significant effect (P > 0.05) of a few factors was observed on disease production. 
Those factors were; multiple person milking, type of housing, age of the animal, type of herd, 
and area of sampling. 
 Non significant effect (P > 0.05) of multiple persons milking was observed in 
diseased animals. Herds where multiple persons were involved in milking, 46.34% pox 
diseased animals were found having chance of infection 37.66 to 55.19 %, and herds where 
milking from one person was in practice, 37.50% pox diseased animals were found having 
chance of infection 23.61 to 53.14 % (Table 4.10). 
 Non significant effect (P > 0.05) of type of housing was observed in diseased 
animals. Herds having shed type of housing , 55% pox diseased animals were found having 
chance of infection 39.50 to 69.80 %, and in loose type of housing, 41.79% pox diseased 
animals were found having chance of infection 30.45 to 53.83 %, and in open type of 
housing, 39.29% pox diseased animals were found having chance of infection 27.19 to 52.47 
% (Table 4.11). 
 Non significant effect (P > 0.05) of age was observed in diseased animals. Herds 
having buffaloes of 2-4 years age, 48.48% pox diseased animals were found having chance 
of infection 36.62-60.48 %, and in herds 5-7 years aged buffaloes were present, 39.68% pox 
diseased animals were found having chance of infection 28.19 to 52.10 %, and herds having 
8-10 years aged buffaloes, 44.12% pox diseased animals were found having chance of 
infection 28.25-60.95 %, and (Table 4.12). 
 Non significant effect (P > 0.05) of type of herd was observed in diseased animals. 
Herds having dairy buffaloes, 45.32% pox diseased animals were found having chance of 
infection 37.19 to 53.65 %, and in herds  mixed (dairy and meat) type of buffaloes were 
reared, 37.50% pox diseased animals were found having chance of infection 20.08 to 57.78 
% (Table 4.13). 
 Non significant effect (P > 0.05) of various area of sampling was observed in 
diseased animals with pox positivity from 0.00% to 76.47% and having chance of infection 
0.00% to 92.04 % (Table 4.14). 
 
71 
 
 
Table 4.10: Effect of milking from multiple persons on BPXV infection in buffaloes 
 
Person involved in milking  Negative  Positive (%)  95% CI  
Multiple person  66  57 (46.34)  37.66-55.19  
One person  25  15 (37.50)  23.61-53.14  
Chi-Square=0.9509, DF=1, P=0.3295 
 
Data subjected to chi-square test revealed non significant effect (P > 0.05) of  
no. of milkers involved in milking on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* DF = degree of freedom 
* P = level of significance 
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Table 4.11: Effect of housing on BPXV infection in buffaloes 
 
Housing  Negative  Positive (%)  95% CI  
Shed  18  22 (55.0)  39.50-69.80  
Loose  39  28 (41.79)  30.45-53.83  
Open  34  22 (39.29)  27.19-52.47  
Chi-Square=1.3806, DF=1, P=0.2400 
 
Data subjected to chi-square test revealed non significant effect (P > 0.05) of  
type of housing on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* DF = degree of freedom 
* P = level of significance 
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Table 4.12: Effect of age on BPXV infection in buffaloes 
 
Age group (year)  Negative  Positive (%)  95% CI  
2-4  34  32 (48.48)  36.62-60.48  
5-7  38  25 (39.68)  28.19-52.10  
8-10  19  15 (44.12)  28.25-60.95  
Chi-Square=0.3530, DF=1, P=0.5524 
 
Data subjected to chi-square test revealed non significant effect (P > 0.05) of  
age of animal on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* DF = degree of freedom 
* P = level of significance 
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Table 4.13: Effect of type of herd on BPXV infection in buffaloes 
 
Dairy/Mix  Negative  Positive (%)  95% CI  
Dairy  76  63 (45.32)  37.19-53.65  
Mix  15  9 (37.50)  20.08-57.78  
Chi-Square=0.5049, DF=1, P=0.4774 
 
Data subjected to chi-square test revealed non significant effect (P > 0.05) of  
type of herd on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* DF = degree of freedom 
* P = level of significance 
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Table 4.14: Effect of area of sampling on BPXV infection in buffaloes 
 
Area Negative  Positive (%)  95% CI  
Lahore  18 22 (55) 39.50-69.80 
Faisalabad  27 14 (34.15) 20.93-49.54 
Nankana Sb  4 4 (50) 15.70-84.30 
Rawalpindi  6 3 (33.33) 9.27-66.76 
Attock  4 13 (76.47) 52.50-92.04 
Okara  9 6 (40) 18.09-65.46 
Sheikhupura  5 4 (44.44) 16.05-75.96 
Bureywala  4 1 (20) 1.00-66.56 
Gujrat  5 4 (44.44) 16.05-75.96 
DG Khan  2 1 (33.33) 1.67-86.80 
Sialkot  5 0 (0) 0.00-45.07 
Gujranwala  2 0 (0) 0.00-77.64 
Chi-Square=2.4766, DF=1, P=0.1155 
 
Data subjected to chi-square test revealed non significant effect (P > 0.05) of  
area of sampling on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* DF = degree of freedom 
* P = level of significance 
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4.1.2. Multivariate logistic regression analysis 
 Association of different factors in disease production was observed by applying 
multivariate logistic regression analysis including all variables with fast backward 
eliminating procedure by the model. Backward eliminated factors by the model were as 
follows:  
a. Introduction of young buffaloes 
b. Total no. of animals 
c. Animals reluctant in milking 
d. Decreased milk production 
e. Septic condition in animals 
f. Milking from multiple persons,  
g. Housing 
h. Area of sampling 
i. Age of animal 
j. Type of herd (dairy/mix).  
 It was found that three factors were significantly associated (P < 0.05) with disease 
progression and those were; skin lesions in milkers, fever in milkers and presence of other 
animal species in the same herd. Further it was seen after calculation of log odd ratios that, 
there is 6.891 times more chance of occurrence of pox disease in herds where “milkers 
having skin lesions” are present as compared with those where milkers don’t have lesions. 
Similarly, there is 5.112 times more chance of occurrence of pox disease in herds where 
“milkers suffering from fever were present as compared with those where milkers were 
having normal temperature. There is 3.481 times more chance of occurrence of pox disease 
in herds where animals other than buffaloes were also reared as compared with those where 
only buffaloes were reared (Table 4.15). 
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Table 4.15:  Factors influencing significantly in BPXV infection including all the  
  variables in buffaloes 
 
Factor  Log odd ratio  95% CI  P < 0.05  
Skin lesions in milkers  6.891  2.720-17.459  <0.0001  
Fever in milkers  5.112  2.195-11.905  0.0002  
Multiple species rearing  3.481  1.486-8.155  0.0041  
 
Log odd ratio indicates likelihood of BPXV infection in buffaloes 
Data subjected to multivariate logistic regression analysis revealed significant effect (P < 
0.05) on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* P = level of significance 
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 Age hides the true association of factors with disease production that’s why after 
controlling the effect of age, analysis of multivariate logistic regression showed that a 
number of factors were significantly associated (P < 0.05) with disease production and those 
factors were;  
a. Person suffering from fever 
b. Person exhibiting skin lesions 
c. Reluctance in milking 
d. Septic condition of animals 
e. Decreased milk production 
f. Multiple species rearing 
g. Introduction of young buffaloes 
h. Total no. of animals.  
 Log odd ratios showed that there is 11.542 times more chance of occurrence of pox 
disease in herds where “persons suffering from fever” were present as compared with those 
where persons don’t suffer from fever. There is 10.306 times more chance of occurrence of 
pox disease in herds where “persons having skin lesions” were present as compared with 
those where persons don’t have skin lesions. There is 5.576 times more chance of occurrence 
of pox disease in herds where “animals were reluctant in milking” were present as compared 
with those where animals were not reluctant in milking. There is 4.541, 4.395, 4.096 times 
more chance of occurrence of pox disease in herds where “septic condition in animals, 
decreased milk yield and multiple species were reared” as compared with those where 
reverse was true. There is 2.773 times more chance of occurrence of pox disease in herds 
where history of addition of young buffaloes was present as compared with those where this 
history was not present. There is 1.041 times more chance of occurrence of pox disease in 
herds where “total number of animals is more” as compared with those where no. of animals 
is less (Table 4.16).  
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Table 4.16: Factors influencing significantly in BPXV infection after controlling  
  the effect of age in buffaloes 
Factor  Log odd ratio  95% CI  P < 0.05 
Person suffering from fever  11.542  5.446-24.465  <0.0001  
Person exhibiting skin lesions  10.306  4.769-22.273  <0.0001  
Reluctance in milking  5.576  2.767-11.240  <0.0001  
Septic condition in animals 4.541  2.002-10.301  0.0003  
Decreased milk production  4.395  2.263-8.535  <0.0001  
Multiple species rearing  4.096  2.066-8.121  <0.0001  
Introduction of young 
buffaloes  
2.773  1.458-5.273  0.0019  
Total animals  1.041  1.017-1.065  0.0009  
 
Log odd ratio indicates likelihood of BPXV infection in buffaloes 
Data subjected to multivariate logistic regression analysis revealed significant effect (P < 
0.05) on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* P = level of significance  
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 Factors which had non significant effect (P > 0.05) in disease production after 
controlling the effect of age were as follows;  
a. Milking from multiple persons 
b. Housing type 
c. Area of sampling 
d. Type of herd i.e. Dairy/mixed 
 Log odd ratios showed that there was 1.406 times more chance of occurrence of pox 
disease in herds where “milking from multiple persons” was in practice. There was 1.252 
times more chance of occurrence of pox disease on the basis of “type of housing”. There was 
0.919 times more chance of occurrence of pox disease on the basis of “area of sampling”. 
There was 1.355 times more chance of occurrence of pox disease on the basis of “type of 
herd” (Table 4.17). 
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Table 4.17: Non influencing factors on BPXV infection after controlling the effect 
  of age in buffaloes 
Factor  Log odd ratio  95% CI  P > 0.05  
Milking from multiple persons  1.406  0.672-2.939  0.3655  
Type of housing  1.252  0.844-1.855  0.2638  
Area of sampling  0.919  0.827-1.023  0.122  
Type of herd (dairy/mix)  1.355  0.554-3.314  0.5058  
 
Log odd ratio indicates likelihood of BPXV infection in buffaloes 
Data subjected to multivariate logistic regression analysis revealed non significant effect (P > 
0.05) on BPXV infection in buffaloes. 
* BPXV = buffalopox virus  
* CI= confidence interval  
* P = level of significance 
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4.2. Gross pathology of BPXV infection  
4.2.1 Buffaloes 
 Different stages of pox lesions in BPX affected animals were mostly seen on teats 
(Plate 4.1) during sampling for this research. Infection was self limiting and in few cases 
complicated with secondary bacterial contamination prolonging the duration of the illness, 
especially mastitis was observed in the affected animals. Different stages of BPX observed 
were; vesicle formation (Plate 4.1-a), deep seated ulcers (Plate 4.1-b), dry scab lesion (Plate 
4.1-c), wet scab with serous exudation (Plate 4.1-d), dry scabs (Plate 4.1-e & 4.1-f), scab 
lesions on all the teats with pits in the centers (Plate 4.2-a) in buffaloes. In another buffalo 
different stages of lesions in the teats were observed. These lesions included; vesiculation, 
wart like nodules, scabs and blood oozing out after removing the scab indicating 
inflammatory lesions (Plate 4.2-b), There were dry scabs in a buffaloes having permanent 
drop in production (Plate 4.2-c), scab with inflammatory lesions beneath it (Plate 4.2-d), dry 
scabs large in size also indicating unhygienic condition pre-disposing to bacterial 
contamination (Plate 4.2-e), In other animal  different stages of BPX lesions including; scab 
formation, inflammatory lesion beneath it and flies feeding the lesions indicating possible 
mechanical carrier for transmitting disease from one animal to another (Plate 4.2-f) were 
recorded. Symptomatic treatment along with the administration of heavy doses of broad 
spectrum antibiotics to combat the infection and steroid injections to ease the animals, have 
been noticed exposing the animal to side effects of these drugs. 
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Plate 4.1: Different stages of pox lesions on teats of BPXV infected buffaloes   
a: vesicle formation, b: deep seated ulcers, c: dry scab lesion, d: wet scab with serous 
exudation, e & f: dry scab lesions. 
* BPXV = buffalopox virus 
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Plate 4.2: Different stages of pox lesions on teats of BPXV infected buffaloes   
a: scab lesions on all the teats with pits in the centers, b: different stages of lesions in the 
teats of same buffaloes including; vesiculation, wart like nodules, scabs and blood oozing out 
after removing the scab, c: dry scabs on teats of buffalo, d: scab with inflammatory lesions 
beneath it, e: dry large scabs, f: different stages of BPX lesions including; scab formation, 
inflammatory lesion beneath it and flies feeding the lesions. 
* BPXV = buffalopox virus, * BPX = buffalopox 
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4.2.2 Milkers 
 A number of human cases infected with BPXV have also been observed during 
survey, exhibiting different stages of pox lesions (Plate 4.3). They were assumed to be 
infected with BPXV, on the basis of history of acquiring infection, fever, scar formation, and 
appearance of characteristic pus filled pitted lesions in the center due to BPX infections. 
Lesions in humans were mostly found on hands, face, around eyes along with high fever. 
Different stages of lesions recorded were; vesiculation on hands (Plate 4.3-a), pustule stage 
along with pits in the centers on a hand of milker (Plate 4.3-b), pus filled lesions on eye of a 
milker (Plate 4.3-c), pus filled lesions, high fever and having no history of direct contact with 
the buffaloes (Plate 4.3-d), regressed lesion still indicating pits in the centers (Plate 4.3-e), 
and scars left after removal of scabs (Plate 4.3-f). 
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Plate 4.3: Different stages of BPX lesions in milkers  
a: vesiculation on hands, b: pustule stage alongwith pits in the centers on a hand of miker, c: 
pus filled lesions on eye of a milker, d: pus filled lesions on eye of a child of milker with 
history of high fever, e: regressed lesion with pits in the centers, f: scars left after removal of 
scabs.  
* BPX = buffalopox 
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4.3. Effect of BPXV infection on hematology 
 Keeping expected prevalence 50%, level of confidence 95% and desired absolute 
precision 10%, a total of 96 herds were visited for data and sample collection. Total animals 
of all the herds were 975, out of these; blood samples from 163 animals were collected.  
 Effect of BPXV infection on hematology of buffaloes at various age groups is shown 
in Table 4.18. Non-significant effect of BPXV infection was observed on erythrocyte count, 
Hb concentration, PCV and PLT of buffaloes at 2-4 years, 5-7 years and 8-10 years of age. 
However, significant increase was observed on WBC count in diseased buffaloes of all age 
groups and this increase was due to increase in number of lymphocytes (Figures 4.1, 4.2 & 
4.3).  
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Table 4.18: Effect of BPXV infection on hematology of buffaloes in 2-4 years,  
  5-7 years, and 8-10 years age groups 
 
Parameter 
2-4 years age group 5-7 years age group 8-10 years age group 
BPXV 
infected 
(Mean±SE) 
Healthy 
(Mean±SE) 
BPXV 
infected 
(Mean±SE) 
Healthy 
(Mean±SE) 
BPXV 
infected 
(Mean±SE) 
Healthy 
(Mean±SE) 
RBC  
(106/µL)  
6.76  
± 0.06 
6.75  
± 0.35 
6.57 
 ± 0.11 
6.15  
± 0.55 
6.51  
± 0.08 
6.55  
± 0.05 
HB Conc.  
(g/dL) 
13.47  
± 0.11 
13.25  
± 0.55 
13.12  
± 0.18 
12.25  
± 1.25 
13.01  
± 0.21 
13.70  
± 0.30 
PCV  
(%) 
33.94  
± 0.50 
33.50  
± 2.50 
33.05  
± 0.79 
31.00  
± 3.00 
32.25  
± 0.41 
34.00  
± 1.00 
WBC  
(103/µL)  
10.41  
± 0.23* 
5.57  
± 0.52 
9.91  
± 0.32* 
7.28  
± 0.68 
9.88  
± 0.31* 
6.78  
± 0.17 
PLT  
(103/µL)  
317.78  
± 7.96 
283.50  
± 23.50 
305.58  
± 7.41 
307.50  
± 12.50 
310.25  
± 4.05 
321.50  
± 8.50 
Neutrophil 
(103/µL) 
3.49  
± 0.37 
2.59  
± 0.08 
3.23  
± 0.29 
2.27  
± 1.07 
3.05  
± 0.55 
3.06  
± 0.13 
Lymphocyte 
(103/µL) 
7.29  
± 0.12* 
3.55  
± 0.55 
6.72  
± 0.08* 
4.64  
± 0.36 
6.41  
± 0.53* 
3.39  
± 0.23 
Monocyte 
(103/µL) 
0.13  
± 0.00 
0.12  
± 0.00 
0.12  
± 0.00 
0.1350  
± 0.02 
0.12  
± 0.01 
0.17  
± 0.03 
Eosinophil 
(103/µL) 
0.24  
± 0.01 
0.30  
± 0.05 
0.21  
± 0.01 
0.18  
± 0.02 
0.27  
± 0.02 
0.22  
± 0.03 
Basophil 
(103/µL) 
0.00  
± 0.00 
0.01   
± 0.00 
0.00  
± 0.00 
0.00  
± .00 
0.00  
± 0.00 
0.00  
± 0.00 
Data subjected to independent student t-test  
Each figure (BPXV infected, 2-4 years age) represents mean of 66 buffaloes ± standard error 
Each figure (BPXV infected, 5-7 years age) represents mean of 63 buffaloes ± standard error 
Each figure (BPXV infected, 8-10 years age) represents mean of 34 buffaloes ± standard error 
Each figure (Healthy animals of all groups) represents mean of seven buffaloes ± standard error 
* indicates significant increase in the values at P < 0.05 
Non significant difference at P > 0.05 
*BPXV = buffalopox virus, *SE = standard error, *RBC = red blood cell, *Hb = hemoglobin, *PCV = pack cell 
volume, *WBC = white blood cell, *PLT = platelet, *P = level of significance 
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Figure 4.1: Effect of BPXV infection on TLC & DLC in buffaloes of 2-4 year age group 
 
*WBC = white blood cell, *neutro = neutrophil, *lympho = lumphocyte, *mono = monocyte, *eosino = 
eosinophil, *baso = basophil, *BPXV = buffalopox virus, *TLC = total leukocyte, *DLC = differential 
leukocyte. 
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Figure 4.2: Effect of BPXV infection on TLC & DLC in buffaloes of 5-7 year age group 
*WBC = white blood cell, *neutro = neutrophil, *lympho = lumphocyte, *mono = monocyte, *eosino = 
eosinophil, *baso = basophil, *BPXV = buffalopox virus, *TLC = total leukocyte, *DLC = differential 
leukocyte. 
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Figure 4.3: Effect of BPXV infection on TLC & DLC in buffaloes of 8-10 year age group  
*WBC = white blood cell, *neutro = neutrophil, *lympho = lumphocyte, *mono = monocyte, *eosino = 
eosinophil, *baso = basophil, *BPXV = buffalopox virus, *TLC = total leukocyte, *DLC = differential 
leukocyte. 
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4.4. Identification of virus through PCR 
 A total no. of 96 herds from different areas of Punjab, were surveyed for sampling 
BPXV. Nineteen scab samples from herds of different localities were collected on different 
time intervals, comprising of two-years. The total amount of viral DNA extracted from each 
scab material (n=19) as estimated from A260 nm value was between 24.5µg and 56.4µg per 
ml. The ratio of OD260/280 for isolated DNAs was between 1.70 and 2.00, which indicated the 
purity of DNA samples. To confirm the presence of BPXV in scab materials, BPXV specific 
PCR was performed. Out of nineteen scab samples, fifteen samples were found positive for 
BPX (78.94%) (Table 4.19). Buffalopox virus was detected by running PCR test with primer 
pair BPXV-C18L-F/BPXV-C18L-R with 100bp DNA ladder and a product of 138bp in BPX 
positive samples, was visualized after agarose (1.5%) gel electrophoresis. This band size was 
specific for amplified C18L genes of BPX from samples of infected animals. Sterile ultrapure 
water was used as negative control and there was no band in this lane indicating accuracy of 
the procedure.  
 Plate 4.4 shows scab samples from different BPXV suspected herds. Lanes 1 to 6 
indicating band size of 138bp are BPXV positive scab samples by PCR and M is 100bp DNA 
ladder as marker. Plate 4.5 also shows scab samples from different BPXV suspected herds. 
Lanes 1 to 6 indicating band size of 138bp are BPXV positive scab samples by PCR and M is 
100bp DNA ladder as marker. 
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Table 4.19: Number of farms showing positive samples of BPXV infection through 
  PCR in different areas of Punjab 
Area  No. of herds 
visited  
No of blood 
samples collected  
Scab samples 
collected  
BPX positive herds 
(on the basis of PCR)  
Lahore  27  38  7  6  
Faisalabad  26  41  3  3  
Nankana Sb  2  8  1  1  
Rawalpindi  4  9  1  0  
Attock  5  19  2  2  
Okara  8  15  1  1  
Sheikhupura  5  9  1  0  
Bureywala  4  5  1  1  
Gujrat  5  9  1  0  
DG Khan  3  3  1  1  
Sialkot  5  5  ---  ---  
Gujranwala  2  2  ---  ---  
 Total=96  Total=163  Total=19  Total=15 (78.94%)  
 
* BPXV = buffalopox virus, * BPX = buffalopox, * PCR = polymerase chain reaction. 
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Plate 4.4: Photograph of PCR results indicating positive BPXV scab samples  
Lanes 1 to 6 are BPX positive scab samples by PCR. M is 100bp DNA ladder 
*BPXV = buffalopox virus, * BPX = buffalopox , *PCR = polymerase chain reaction, *bp = 
base pair 
 
 
 
500bp 
100bp 138bp 
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Plate 4.5: Photograph of PCR results indicating positive BPXV scab samples  
Lanes 1 to 6 are BPX positive scab samples by PCR. M is 100bp DNA ladder 
*BPXV = buffalopox virus, * BPX = buffalopox , *PCR = polymerase chain reaction, *bp = 
base pair 
 
500bp 
100bp 138bp 
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4.5. Preparation of vaccine 
4.5.1. Cytopathic effects on Vero cells by BPXV 
 Virus was attenuated on Vero cells by serial passages for vaccine development. Vero 
cells started showing CPEs at 3-DPI. After 3 cycles of freezing and thawing the virus 
suspension was centrifuged to remove cell debris and the supernatant was collected and 
stored at -20oC. In this way the virus was serially passaged in Vero cell culture. During initial 
passage the CPE was started appearing after 72 hr while after 25th passages it took only 20 
hr for the appearance of CPE.  
 Different stages of Vero cells (normal cells and cells with CPEs) are shown in Plate 
4.6. Normal Vero cells without infection were spindle shaped with sharp edges at day-4 of 
dispensing (Plate 4.6-a). After viral inoculation Vero cells started rounding on the edges at 4-
DPI due to the action and multiplication of virus in the cells (Plate 4.6-b). These cells became 
more round at 5-DPI (Plate 4.6-c). From 6-DPI to 7-DPI CPEs were gradually increased 
(Plates 4.6-d & 4.6-e), and these became more than 90% at 8-DPI (Plate 4.6-f). 
 
 
97 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plate 4.6: Development of cytopathic effects in normal and BPXV infected Vero cells  
a: normal Vero cells with sharp edges at day-4 of dispensing without infection, b: cells 
started rounding on the edges at 4-DPI due to the action of virus, c: more rounding of cells at 
5-DPI as compared with at 4-DPI, d: CPEs increased at 6-DPI compared to previous day, e: 
more CPEs at 7-DPI, f: more than 90% CPEs at 8-DPI 
*BPXV = buffalopox virus, * DPI = day-post-infection, *CPEs = cytopathic effects. 
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4.5.2. Gross pathology in rabbits 
During viral attenuation process, various stages of pox lesions were observed on skin 
of rabbits after infection with pathogenic BPXV. Patches of congestion were observed after 
virus inoculation into epithelial cells, and then due to proliferation of cells by the action of 
virus there was papule formation. An inflammatory hyperemia was followed by serous 
exudation of corneum leading to vesiculation stage. Due to entry of leukocytes into the 
vesicle, pustule stage was developed. Then pustules dried forming a scab/crust which case 
off (desquamative stage). Fresh epithelium covered the lesion from the edges.  
Day wise development of lesions was as follows; papule formation alongwith zone of 
hyperemia at 2-DPI. This stage remained upto 3-DPI. Then vesicle formation with zone of 
hyperemia 4–DPI indicating more pronounced swelling (Plate 4.7-a) was observed. This 
stage remained upto 5-DPI but increased in size due to marked swelling.  
At 7-DPI, pustules were remained as such (Plate 4.7-b) and regressed at 8-DPI with 
decrease in size of swelling (Plate 4.7-c). Zone of hyperemia was still present around the 
lesion.  
At 9-DPI, pustule stage started subsiding at most of the injected sites but it was still 
present at two-points but low in severity as compared to at 8-DPI. At 10-DPI, lesions started 
progressing towards crust formation with pits in the centre (Plate 4.7-d). There was marked 
decrease in zone of hyperemia.  
 At 12-DPI, lesions were at pit forming stage and progressing towards crust formation 
(Plate 4.7-e). At 13-DPI, scab formation started and scabs sloughed off at 15-DPI leaving 
scar (Plate 4.7-f). The whole case comprised of 2 to 3 weeks. 
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Plate 4.7: Gross pathological changes in rabbits after BPXV inoculation   
a: vesicle formation with zone of hyperemia at 4-DPI with pronounced swelling, b: pustules 
formed at 7-DPI with zone of hyperemia, c: at 9-DPI, pustule stage started subsiding at most 
of the injected sites but it was still present at two-points but low in severity as compared to at 
8-DPI, d: at 10-DPI, lesions started progressing towards crust formation with pits in the 
centre with decrease in zone of hyperemia, e: at 12-DPI, lesions at pit forming stage and 
progressing towards crust formation, f: at 13-DPI, scab formation started and scabs sloughed 
off at 15-DPI leaving scar. 
*BPXV = buffalopox virus, *DPI = day-post-infection.
36 
38 
34 
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4.5.3. Pathological changes in rabbits after BPXV inoculation at different passages 
There was significant but gradual decrease of viral pathogenicity with increasing 
passage level in Vero cells. Initially upto 30th passage the rabbits developed severe reaction 
which was observed 48 hpi showing severe response, weakness, debilitation, diarrhoea and 
fever. On subsequent passages, there was marked reduction of virulence. At start, after every 
five passages, attenuation status of the virus was assessed in the rabbits by inoculating I/D to 
determine its degree of infectivity. After 40th passage, this was checked for every passage 
because the degree of infectivity was decreased to a greater extent and attenuation status was 
near to achieve. The virus was sufficiently attenuated at 51st passage level for the rabbits as 
it did not produce any lesion in one-rabbit whereas the one-rabbit exhibited mild 
erythematous reaction at 36-hpi which subsided within 24 hr (Table 4.20). Detail of 
pathology at various passages was as follows;  
 At 10th passage, severe skin reaction observed 48hr-PI. A roseolar erythema followed 
by firm, raised papule light in colour with a zone of hyperemia around the base was observed 
at 2-DPI. Marked swelling at 72hr was observed, which latter on increased in thickness. 
Rabbits became weak, debilitated and suffered from diarrhoea and fever. A characteristic 
yellow blister with a pitted centre was noticed at 5-DPI. There was diarrhoea at 7 and 8-DPI. 
 At 20th passage, severe lesions were observed 48hr-PI which increased in thickness 
and formed yellow blister with pitted centre. Rabbits recovered in 3 weeks. 
 At 30th passage, severe lesions observed 48hr-PI which increased in thickness. The 
rabbits recovered in 3 weeks.  
 At 40th passage, skin lesions observed but subsided after 5 days. 
 At 51st passage, one rabbit showed mild erythema 36-hpi but subsided within 24hr. 
Again, two rabbits were injected for confirmation, no skin reaction was observed at the site 
of inoculation in both rabbits. 
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Table 4.20: Assay of infectivity of Vero cell culture attenuated BPXV 
  inoculated intradermally in the skin of rabbits 
Passage 
level 
Observation (lesion/reaction) 
10th  Severe skin reaction observed 48hr-PI. A roseolar erythema followed by firm, 
raised papule light in colour with a zone of hyperemia around the base was 
observed 2-DPI. Marked swelling at 72hr which latter increased in thickness. 
Rabbits became weak, debilitated and suffered from diarrhoea and fever. A 
characteristic yellow blister with a pitted centre was noticed on day 5-PI. There 
was diarrhoea on day 7 and 8. 
20th Severe lesions observed 48hr-PI which increased in thickness and formed yellow 
blister with pitted centre. The rabbits recovered in 3 weeks. 
30th Severe lesions observed 48hr-PI which increased in thickness. The rabbits 
recovered in 3 weeks.  
40th Skin lesions observed but subsided after 5 days. 
51st  One rabbit showed mild erythema after 36-hpi but subsided within 24hr. Again, 
two rabbits were injected for confirmation, no skin reaction was observed at the 
site of inoculation in both rabbits. 
 
*BPXV = buffalopox virus, *PI = post-infection, *DPI = day-post-infection, *hr = hour, *hpi 
= hour-post-infection 
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4.5.4. Histopathological changes in rabbit skin after infection with BPXV  
 Histopathology of epidermis and dermis of the rabbits from healthy normal and pox 
infected rabbits were done. Lesions observed in dermis and epidermis are shown in Plate 4.8. 
The histological evaluation of the cutaneous lesions revealed marked hyperkeratosis in 
epidermis. Mononuclear cell infiltration in connective tissue of dermis and vacuolar 
degeneration of keratinocytes was observed. Most keratinocytes were characterized by 
ballooning degeneration with large intracytoplasmic, eosinophilic inclusion bodies.  
 Epidermis & dermis of a skin of rabbit of control group (Plate 4.8-a) showed no 
hyperkeratosis There was hyperkeratosis with accumulation of dense basophilic keratin 
granules in epidermis (arrow head) and mononuclear cell infiltration in dermis (arrows) 
(Plate 4.8-b) of rabbit inoculated with BPXV. The dermis of a normal skin showed dense 
connective tissue (Plate 4.8-c). There was mononuclear cell infiltration in connective tissue 
of dermis (Plate 4.8-d), vacuolar degeneration of keratinocytes in stratum spinosum (Plate 
4.8-e) in infected rabbits. Vacuolar degeneration of keratinocytes with intracytoplasmic 
eosinophilic inclusion bodies in stratum spinosum (Plate 4.8-f) was observed in skin of rabbit 
which was inoculated BPXV. 
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Plate 4.8: Histopathological changes in rabbit skin after infection with BPXV 
a: epidermis & dermis of a normal skin, b: hyperkeratosis with accumulation of dense 
basophilic keratin granules in epidermis (large arrow) and mononuclear cell infiltration in 
dermis (small arrows), c: dermis of a normal skin showing dense connective tissue, d: 
mononuclear cell infiltration in connective tissue of dermis, e: vacuolar degeneration of 
keratinocytes in stratum spinosum (arrows), f: vacuolar degeneration of keratinocytes with 
intracytoplasmic eosinophilic inclusion bodies in stratum spinosum (arrows). 
*BPXV = buffalopox virus 
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4.5.5. Sterility test of vaccine 
The wet material was subjected to sterility test by inoculating 0.1 mL of viral 
suspension in nutrient broth, nutrient agar, MacConkey’s agar, blood agar and Sabouraud’s 
agar. Media was incubated at 37oC. No contamination was found after incubation of these 
culture plates at 37oC upto 48 hours.  
4.5.6. Safety test of vaccine 
Five rabbits were injected via IM route with 1.0 mL of TCID50 10-2.5 attenuated viral 
suspension each and one rabbit was kept as negative control (1.0 mL normal saline was 
injected). Temperature and appearance of local reactions were recorded daily for 9 days. 
Temperature remained normal and no skin lesions were found during this period in both the 
groups (virus inoculated and negative control). 
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4.6. Efficacy of BPXV vaccine  
4.6.1. Estimation of viral contents of vaccinal material 
 Vero cells were counted by haemocytometer. Cells were diluted to the recommended 
concentration of 2-3x105 cells/ml before dispensing into the tissue culture flasks. Percentage 
of dead cells differed at different working times from 25.12% to 36.36% and that of live cells 
from 63.64% to 74.88%. Cumulative totals of wells with CPEs and that of wells without 
CPEs were calculated to determine percentage of infections in wells. Dilution factor was 10 
and the starting point dilution (the dilution showing percentage of infected next below 50%) 
was 10-3(Table 4.21). 
“Difference of logarithms” was calculated by the following formula: 
50% - (percentage of infected next below 50%)  x log of dilution factor 
(percentage of infected next above 50%) –  
(percentage of infected next below 50%) 
 
Hence, the “Difference of logarithms” was; 
50 – 33.33  x 1 = 0.5 
66.67 – 33.33 
Log (reciprocal of 50% end-point dilution) 
= log (reciprocal of 50% starting-point dilution) – difference of logarithms 
=log 10-3 – 0.5 = 3 - 0.5 = 2.50 
Hence, log (50% end-point dilution) = - 2.50 
And  
50% end-point dilution (TCID50 titre) = 10-2.5 (viral contents per mL) 
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Table 4.21: Estimation of viral contents of vaccinal material 
 
Virus dilution No. of wells Cumulative totalsa Percentage infected  
Without CPE With CPE Without CPE With CPE 
10-1 1 4 1 10 10/11 = 90.91% 
10-2 2 3 3 6 6/9 = 66.67% 
10-3 3 2 6 3 3/9 = 33.33% 
10-4 4 1 10 1 1/11 = 9.09% 
10-5 5 0 15 0 0/15 = 0% 
10-6 5 0 20 0 0/20 = 0% 
10-7 5 0 25 0 0/25 = 0% 
 
aTotals were accumulated from 10-1 to 10-7 for wells without CPE and from 10-7 to 10-1 for 
wells with CPE. 
*CPE = cytopathic effect 
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4.6.2. Calculation of TCID50 from wild type of virus for challenge dose preparation 
 Cumulative totals of wells with CPEs and that of wells without CPEs were calculated 
to determine percentage of infections in wells. Dilution factor was 10 and the starting point 
dilution (the dilution showing percentage of infected next below 50%) was 10-5(Table 4.22). 
“Difference of logarithms” was calculated by the following formula: 
50% - (percentage of infected next below 50%)  x log of dilution factor 
(percentage of infected next above 50%) –  
(percentage of infected next below 50%) 
 
Hence, the “Difference of logarithms” was; 
50 – 5  x 1 = 0.86 
66.67 - 14.28 
Log (reciprocal of 50% end-point dilution) 
= log (reciprocal of 50% starting-point dilution) – difference of logarithms 
=log 10-5 – 0.86 = 5 - 0.86 = 4.14 
Hence, log (50% end-point dilution) = - 4.14 
And  
50% end-point dilution (TCID50 titre) = 10-4.14 per 1mL 
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Table 4.22: Calculation of TCID50 from wild type of virus for challenge dose 
preparation 
 
Virus dilution No. of wells Cumulative totalsa Percentage infected  
Without CPE With CPE Without CPE With CPE 
10-1 0 5 0 19 19/19 = 100% 
10-2 0 5 0 14 14/14 = 100% 
10-3 0 5 0 9 9/9 = 100% 
10-4 2 3 2 4 4/6 = 66.67% 
10-5 4 1 6 1 1/7 = 14.28% 
10-6 5 0 11 0 0/11 = 0% 
10-7 5 0 16 0 0/16 = 0% 
 
aTotals were accumulated from 10-1 to 10-7 for wells without CPE and from 10-7 to 10-1 for 
wells with CPE. 
*CPE = cytopathic effect 
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4.6.3. Challenge dose preparation 
a. Log dilution of challenge preparation containing 10 TCID50 of virus per 1 mL 
 = log 10-4.14 – log 10 = 4.14 – 1 = 3.14 
 Since 3.14 = log 1380, this meant that 0.38 mL of diluent was add for every 1mL of 
 the 10-3 dilution. The final dilution then contained 10 TCID50 of virus per 1 mL. 
b. Log dilution of challenge preparation containing 100 TCID50 of virus per 1 mL 
 = log 10-4.14 – log 100 = 4.14 – 2 = 2.14 
 Since 2.14 = log 138, this meant that 0.38 mL of diluent was add for every 1mL of 
 the 10-2 dilution. The final dilution then contained 100 TCID50 of virus per 1 mL. 
c. Log dilution of challenge preparation containing 1,000 TCID50 of virus per 1 mL 
 = log 10-4.14 – log 1,000 = 4.14 – 3 = 1.14 
 Since 1.14 = log 13, this meant that 0.3 mL of diluent was add for every 1mL of the 
 10-1 dilution. The final dilution then contained 1,000 ID50 of virus per 1 mL. 
4.6.4. Preventable fraction of vaccine 
 Twelve-rabbits were immunized with 1.0 mL of 102.5 TCID50 of viral suspension via 
I/D route. Twelve-rabbits were kept as control (1.0 mL normal saline was injected via I/D 
route). In first experiment, 21-DPI, six-rabbits from pre-immunized group were challenged 
with 100 TCID50. Six-rabbits from control group were also injected with 100 TCID50 of 
virulent field isolate of BPXV via I/D route. Rabbits were observed daily for 7 days. No skin 
lesions were found during this period in rabbits of pre-immunized group, whereas all the 
rabbits of control group developed skin lesions. Preventable fraction (PF) by vaccine was 
100% at 100 TCID50 challenge. In second experiment, 21-DPI, six-rabbits from pre-
immunized group were challenged with 1000 TCID50. Six-rabbits from control group were 
also injected with 1000 TCID50 of virulent field isolate of BPXV via I/D route. Rabbits were 
observed daily for 7 days. No skin lesions were found during this period in four-rabbits of 
pre-immunized group (Plates 4.9-a & 4.9-b), however, two-rabbits developed very mild type 
of skin reaction at inoculation site which subsided within 24 hr, whereas all the rabbits of 
control group developed skin lesions. Preventable fraction (PF) by vaccine was 66.67% at 
1000 TCID50 challenge (Table 4.23). Wet material of vaccinal virus at 51st passage and its 
lyophilized form for long term stability are shown in Plates 4.9-c &4.9-d, respectively.  
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Table 4.23: Protective efficacy of BPX vaccine in rabbits (on lesion basis) 
 
Challenge with 100 TCID50  
Control  (n=6)   Immunized rabbits (n=6)  
Lesions produced  (+++)  
(0% protection)  
No lesions produced   
(100% protection)  
Challenge with 1000 TCID50  
Control (n=6)  Immunized rabbits (n=6)  
Lesions produced (+++)  
(0% protection)  
No lesions produced in 4-rabbits 
Lesions produced in 2-rabbits (+) 
(66.67% protection)  
 
+ = very mild reaction that subsided within 24hr 
+++ = severe reaction and rise of body temperature 
PF = 100%   (with 100 TCID50 challenge) 
PF = 66.67%   (with 1000 TCID50 challenge) 
*BPX = buffalopox, *TCID50 = tissue culture infective dose 50, *PF = preventable fraction. 
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Plate 4.9: Preventable fraction of BPXV vaccine 
a: no skin lesions in pre-immunized rabbit after challenge with BPXV, b: no skin lesions in 
pre-immunized rabbit after challenge with BPXV, c: wet material of vaccinal virus at 51st 
passage in tissue culture flask, d: lyophilized form of vaccinal virus in vials and wet material 
in tissue culture flask 
*BPXV = buffalopox virus
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CHAPTER 5 
DISCUSSION 
 Buffalopox is a contagious, infectious viral disease of zoonotic importance that 
affects humans, cattle and buffaloes (Bhanuprakash et al., 2010). Causative agent belongs to 
the genus OPXV in the family Poxviridae (Matthews, 1982). This disease has a short 
incubation period of about 4 days but have a long course of 3 to 4 weeks. Buffalopox 
occurred in epidemic and sporadic forms in Bangladesh, Egypt, India, Pakistan, Indonesia, 
Italy and Russia (Essbauer et al., 2010). This disease leads to huge economic losses due to 
high morbidity rate up to 80% in affected herds (Singh at al., 2006a), and 40-70% reduction 
in milk production (Essbauer et al., 2010). In one district of Punjab, Pakistan its prevalence is 
50% (Khan, 2010). As BPX has zoonotic importance, it leads to infection in human beings 
working in close contact with animals (Ghosh et al., 1977; Lal and Singh, 1977; Singh et al., 
2007; Bhanuprakash et al., 2010; Gurav et al., 2011). In this disease, generally lesions are 
localized on teats, udder, medial aspect of thighs, lips, eyes and nostrils (Sharma, 1934; 
Bhatia, 1936; Wariyar, 1937; Ramakrishna and Ananthapadmanabham, 1957; Singh and 
Singh, 1967; Mallick and Dwivedi, 1982; Chandra et al., 1987; Mallick, 1988; Muhammad et 
al., 1998; Singh et al., 2007; Chandranaik et al., 2011). Buffalopox infection leads to fever, 
rash, inguinal lymphadenopathy, and development of pox lesions on hands and face of 
persons working in close contact with infected buffaloes (Gurav et al., 2011). Due to 
economic and zoonotic importance of BPXV, a project was planned to study its 
epidemiology and to control it by preparation of attenuated vaccine. 
5.1. Epidemiology 
 The present study showed a significant effect (P < 0.05) of milker’s fever, milker’s 
skin lesions, presence of multiple species in the same herd, introduction of young buffaloes, 
total no. of animals, reluctance of animals in milking, milk yield and septic condition of 
animals with different percentages of pox positive animals, in BPX production. Non- 
significant effect (P > 0.05) of following factors was observed on disease production; 
multiple person milking, type of housing, age of the animal and type of herd. 
 Multivariate logistic regression analysis revealed that introduction of young 
buffaloes, total no. of animals, animals reluctant in milking, decreased milk production, 
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septic condition in animals, milking from multiple persons, housing, area of sampling, age of 
animal and type of herd (dairy/mix) were backward eliminated factors. It was found that 
three factors were significantly associated (P < 0.05) with disease progression i.e. skin 
lesions in milkers, fever in milkers and presence of other animal species in the same herd. 
Log odd ratios showed that there were 6-times, 5-times and 3-times more chance of 
occurrence of pox disease in herds where milkers having skin lesions, milkers suffering from 
fever and animals other than buffaloes were also reared in the same herd, respectively. Age 
hides the true association of factors with disease production that’s why after controlling the 
effect of age, analysis of multivariate logistic regression showed that a number of factors 
were significantly associated (P < 0.05) with disease production and those factors were; 
person suffering fever, person skin lesion, reluctant in milking, septic condition of animals, 
decreased milk production, presence of other species, introduction of young buffaloes and 
total no. of animals. Log odd ratios showed that there is 11-times, 10-times, 5-times, 4-times, 
4-times, 4-times, 2-times and 1-times more chance of occurrence of pox disease in herds 
where persons suffering from fever, persons having skin lesions, animals reluctant in 
milking, septic condition in animals, decreased milk yield, rearing other animals alongwith 
buffaloes, addition of young buffaloes and total number of animals was more, respectively. 
Factors which had non significant (P > 0.05) effect in disease production were; milking from 
multiple persons, housing type, area of sampling, type of herd (dairy/mix). The significant 
factors in epidemiological studies, might act as risk factors for pox production. Rehfeld et al. 
(2013) also reported that the heterogeneity of the herd, race, age, body condition and 
individual factors inﬂuence the BPX phenomenon. 
 The disease caused by VACV in cows is known as BV, and it causes a significant 
reduction in milk production and increases susceptibility to secondary bacterial infections, 
such as mastitis (Trindade et al., 2003; Lobato et al., 2005). In our study, different stages of 
lesions in BPX infected buffaloes were noticed on teats most of the time. Trindade et al. 
(2008) observed in naturally infected cows, that BV lesions begin with red papules on the 
skin of teats and sometimes the udder, evolving to vesicles. Three to four days later, these 
lesions become umbilicated pustules surrounded by inﬂammatory tissue and then turn into 
ulcers, until complete wound healing occurs. During surveying, skin lesions suspected for 
BPXV were also recorded of varying degrees of severity and at various stages alongwith high 
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fever in humans. However, these lesions were not confirmed by PCR, and there is every 
possibility of the virus to be present in milk or milk products. Trindade et al. (2008) also 
observed that pox infection in humans was characterized by the presence of ulcerative and 
pustular lesions on the hands, forearms and face, in addition to fever, pain and 
lymphadenopathy (Lobato et al., 2005). Previous studies revealed the presence of VACV 
DNA as well as infectious virus in milk from naturally infected cows (Abrahao et al., 2009a). 
Moreover, infectious VACV was recovered from cheese and cheese whey produced with 
experimentally contaminated milk (de-Oliveira et al., 2010). Although no cases of VACV 
human infection have been identified in Brazil through the consumption of milk from 
diseased cows, a strain of VACV, Buffalopox virus, which affects buffaloes in India, was 
described as the etiological agent of oropharyngeal lesions in humans who consumed 
unpasteurized milk (Berkelman, 2003). Association of decreased milk yield was observed in 
disease condition in this study. Lobato et al. (2005) and Trindade et al. (2006) observed that 
secondary infections, such as mastitis, are a common finding in cows infected with VACV in 
the field and in buffaloes infected by BPXV (Singh et al., 2007), which contribute to reduced 
milk production. Rehfeld et al. (2013) in his experiment with BV also observed that milk 
production decreased by 32.94%, showing that dairy herds affected by BV suffer a great 
economic impact. However, immersion of the teats in antiseptic solutions before and after 
milking helps in the prevention of mastitis and other diseases, such as herpetic mamilite 
(Almeida et al., 2008), BV (de-Oliveira et al., 2011) and pseudocowpox. The decrease in 
milk production could be explained by the inhibition of lactogenesis caused by the action of 
DMS used as a routine practice in field, and similar findings were observed by Greco and 
Stabenfeldt (2002).  
5.2. Pathology of buffalopox 
5.2.1. Pathology in buffaloes  
 Different stages of pox lesions in BPX affected animals were mostly seen on teats 
during survey. Infection was self limiting and in few cases complicated with secondary 
bacterial contamination prolonging the duration of the illness, especially mastitis was 
observed in the affected animals. Different stages of BPX observed were; vesicle formation, 
deep seated ulcers, wet scabs with serous exudation, dry scab lesion, scab lesions on all the 
teats with pits in the centers, different stages of lesions in the teats of same buffaloes 
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including; vesiculation, wart like nodules, scabs and blood oozing out indicating 
inflammatory lesions, dry scabs in a buffalo having permanent drop in production, flies 
feeding the lesions indicating possible mechanical carrier for transmitting disease from one 
animal to another. These findings are in agreement with the findings of Singh et al. (2007) 
who stated that now general form of the disease is rare as reported in previous years, whereas 
severe localized forms of the disease are prevalent affecting the udder and teats, leading to 
mastitis therefore decreasing production potential of buffaloes. 
 Symptomatic treatment along with the administration of heavy doses of broad 
spectrum antibiotics to combat the infection and steroid injections to ease the animals, have 
been noticed exposing the animal to side effects of these drugs, definitely decreasing milk 
yield of the buffaloes. Rehfeld et al. (2013) also found that treatment with antibiotics and 
administration of steroid to avoid secondary infections, lead to immunosuppression and 
decrease productivity. Venkatesan et al. (2010) stated that disease inflicted decline in trade of 
animals and a loss of about 40% in terms of reduced milk production after BPXV infections. 
However, permanent drop in milk yield has also been observed in severe mastitis cases in 
BPXV infected herds (Singh et al., 2006a; Singh et al., 2007). 
5.2.2. Pathology in milkers 
 A number of human cases infected with BPXV have been observed during sampling 
for this disease, exhibiting different stages of pox lesions. They were assumed infected with 
BPXV, on the basis of history of acquiring infection and high fever. Lesions in humans were 
mostly found on hands, face and around eyes. Different stages of lesions recorded were; 
vesiculation on hands, pustule stage alongwith pits in the centers on hand of mikers, pus 
filled lesions on eyes, high fever, regressed lesion with pits in the centers, and scar formation. 
Gurav et al. (2011) and Venkatesan et al. (2010) also found similar types of lesions in 
milkers in India. 
 During this research, lesions on eyes of kids having no history of direct contact with 
the buffaloes were also noticed that might be due to man to man transfer of BPX as other 
related pox viruses like VACV were transmitted from human to human by direct contacts and 
caused serious illness, including death, especially in immunocompromised people. Moreover, 
fetal VACV infection, transmitted from a mother to her fetus can result in rare, but lethal 
(Cono et al., 2003; Sepkowitz, 2003). 
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5.3. Hematology in BPXV infection 
 Non-significant difference was observed on RBC count, Hb concentration, PCV and 
PLT in diseased and healthy animals. However, significant increase on WBC count was 
observed in diseased buffaloes and this increase was due to increase in number of 
lymphocytes regardless of age groups of animals. These findings are in agreement with the 
results of Rehfeld et al. (2013) who after infection in cow with bovine VACV saw that there 
was leukocytosis with neutrophilia and lymphocytosis. In our study neutrophilia was not 
observed. It’s possible reason could be the stage of disease when we collected the blood 
samples, as bacterimia (usually leads to neutrophilia) stage might has vanished due to the 
administration of antibiotics, because it is a usual practice in the field to combat any type of 
infection. Other reasons might be that our experiment was not controlled type regarding 
sampling from buffaloes or sampled buffaloes may be the affectee of re-infection. Similar 
trend was also observed by Rehfeld et al. (2013) when they re-infected the cow with BV 
experimentally, because hematological results suggested no changes in cows that were re-
infected. Lymphocytes were observed in histological slides of BPXV infected buffaloes and 
lymphocytosis in blood analysis, that propose a response to viral infection. Neutrophilia in 
pox infections could be due to mastitis in findings of other researchers like; Paes et al. (2009) 
and Rehfeld et al. (2013). In the scenario of pox infections, and treatment with antibiotics 
and steroid administration to avoid secondary bacterial pathogen complications, mostly 
causing mastitis, may lead to immunosuppression. Rehfeld et al. (2013) experimentally 
induced immunosuppression in cows. The hematological findings of the cows that were 
previously treated with DMS, proposed that the procedure was successful in causing 
immunosuppression. Severe neutrophilia was caused by corticoid due to impairment of 
adhesion molecules of neutrophils that retain the neutrophils in circulating blood (Paes et al., 
2009; Rehfeld et al., 2013). Second reason of lymphopenia might be due to corticosteroid 
action as they cause redistribution of T-lymphocytes and lympholysis (Cohen, 1991). They 
also directly hinder lymphocyte proliferation and activation by inhibiting IL-2 and IL-2 
receptor production, and indirectly reducing synthesis of lymphocyte IL-2 by decreased 
synthesis of monocyte IL-1 (Ross et al., 1990).  
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5.4. Identification of virus 
The conventional isolation methods for BPXV consist of inoculation of virus in 
animal hosts including cattle, buffaloes or passaging in CAM. Conventional biological 
techniques have certain restrictions in identification and differentiation of poxviruses. Assays 
based on PCR have been demonstrated for identification and differentiation of poxviruses 
like MPXV, VACV, CPXV and VARV, based on HA genes and inclusion bodies (Knight et 
al., 1995; Ropp et al., 1995; Meyer et al., 1997, Damaso et al., 2000). In the present study 
instead of using old conventional diagnostic methods for BPXV, the current molecular 
diagnostic technique i.e. PCR has been used by amplifying C18L gene. The C18L gene 
homologue of VACV in BPXV is present at the terminal region of poxvirus genome and the 
ORF encoding 150-aa ankyrin repeat protein determining host range of virus is 453 nt long, 
and that was the reason for amplifying this gene in this study. Yadav et al. (2010), 
Chandranaik et al. (2011) and Gurav et al. (2011) from other geographical regions also 
reported the BPXV by amplifying ATI gene and found encouraging results. In our study, a 
total of 15 suspected scab samples, out of 19 samples, were detected as BPX infected cases. 
The remaining 4 negative cases but suspected for BPX positive cases might be infected with 
“orf”, milker’s nodule or other scab producing bacterial or viral diseases. These negative 
cases need to be verified further by amplifying their respective sets of primers or with 
culturing for bacterial isolation. It is evident from these findings that high ratio (78.94%) of 
BPX amongst the other scab producing diseases (21.06%) existed in the studied population. 
These results strengthen the findings of Khan (2010) who reported high prevalence of BPX 
i.e. upto 50% in one district of Pakistan. However, this figure was not based on scientific 
grounds but investigated through conflation of data based upon participatory appraisal and 
scanning surveillance, however, true picture might be something else if precisely described 
on laboratory findings. In our study, reasons for high ratio might be milking of multiple 
animals by one person and unhygienic conditions, furthermore, domestic flies might be 
playing a significant role as mechanical carrier by feeding one wound and transferring 
infection onto other as also indicated in a very representative Plate 4.2-f. Presence of BPXV 
in the humans (milkers and animal handlers) as noticed in this study is in concomitant with 
study of Zafar et al., (2007) who noticed hospital acquire BPXV infections in humans (burns 
patients and paramedical staff) in Pakistan. Lesions in our study were mainly found on teats 
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in buffaloes and humans developed lesions on face, hands and around eyes along with high 
fever. Almost similar results were found by Bhanuprakash et al. (2010) who found that in 
most of the buffaloes, pox lesions were limited to udder and teats, and in milkers these were 
present mostly on forehead, forearms, and hands, along with exhibiting fever, general 
malaise and axillary lymphadenopathy. Our findings are in also in correlation with the results 
of Singh et al. (2007) who stated that now general form of the disease is rare as reported in 
previous years, whereas severe localized forms of the disease are prevalent affecting the 
udder and teats, leading to mastitis therefore decreasing production potential of buffaloes. 
These findings strongly suggest that virus, perhaps are changing host after gaining access to a 
variety of species and might be depicting a very different or severe pathogenicity in future. In 
addition to economic losses conferred in animals, this warrants special attention in humans as 
the virus, after repeated passages in human population, may acquire virulence and might lead 
to human to human transmission (as it happens in buffalo to buffalo transmission) that will 
be more serious than in the animals. A number of researchers (Kolhapure et al., 1997; Singh 
et al., 2006; Bhanuprakash et al., 2010; Venkatesan et al., 2010) from other geographical 
locations have reported the presence of BPXV circulating in the animal and humans.  
5.5. Preparation of BPXV vaccine 
 Preclinical trials, generally in animal models are conducted for any candidate vaccine, 
to be used in future in humans that’s the reason we also used rabbits in our experiments of 
vaccine development. Sutter et al. (1994) also described that definite appraisal of protective 
efficacy for a given target disease in animals critically depends on representative animal 
models. In our study, 51st passage of BPXV in Vero cells, showed 100% protection against 
the challenge in rabbits. Results of Mohanty and Rai (1989) also showed that Vero cell 
culture adapted BPXV completely attenuated at 40th passage for buffaloes and rabbits. It 
induced high level of humoral and cell mediated immune response in buffaloes as well as in 
rabbits. Difference of passage level’s attenuation in both the studies might be due to variation 
of severity of our isolate. However, challenges with field isolates showed its efficacy and it 
should be added in routine vaccination schedules of livestock to avoid economic losses due 
to this disease in animals and definitely to decrease its transmissibility in human; a zoonotic 
threat. In the experiments of Rehfeld et al. (2013), seroconversion occurred in all cows at the 
10-DPI and at 16-DPI of bovine VACV injection. Neutralizing antibodies were detected in 
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high titers until the end of the experiment. All cows produced TA and NA anti-VACV 
antibodies, starting at 10 and 16-DPI, respectively. In our study antibodies would also be 
produced as the rabbits in both the groups survived the challenge with pathogenic field 
isolate of BPXV. The hyperproteinemia and hyperglobulinemia in pox infections occurred 
due to the increase in antibody titers because the albumin values remained between the 
established reference ranges for bovines (Rehfeld et al., 2013). In our study 
hyperglobulinemia would have occurred because of survival of rabbits in the challenge 
conditions as gamma globulins are antibodies that are produced in immunological responses 
and theses are part of the protein in serum. In our experiments of vaccine efficacy, 2-rabbits 
developed very mild type of lesions which subsided after 24 hr and it is in agreement with 
the findings of Rehfeld et al. (2013) who discussed that lesions appeared only in the 
inoculation site, and the non-inoculated abraded teat remained without lesions throughout the 
experimental infection in cow. However, they found that bovine VACV DNA was found in 
swabs taken from the ulcers in the oral mucosa of infected and immunosuppressed animals, 
which could suggest systemic dissemination of virus and its proliferation in 
immunosuppressed cows. Prior to eradication of smallpox, VACV vaccines greatly prevented 
its incidence, by cross protecting against other OPXVs (Bray, 2006). A good number of 
present population of the world has never been vaccinated with poxviruses. To avoid these 
pathogens crossing from their reservoir hosts to the humans, there is no more an immune 
barrier (Bray, 2009). So, possible emergence of poxviruses from their natural reservoir to 
become a fully human-adapted pathogen cannot be underestimated. High clinical frequency 
of VACV infection was observed, during BV outbreak, even in vaccinated individuals (Silva-
Fernandes et al., 2009). A hypothetical model of the VACV transmission cycle illustrated 
that peridomestic rodents can transmit VACV between humans, cattle or wild animals 
(Abrahao et al., 2009).  
5.5.1. Pathology of BPXV in rabbits  
 The incubation period in experimentally infected rabbits with BPXV was very short 
i.e. 4 days. Other researchers also observed similar trends of incubation period i.e. between 2 
and 4-DPI. Incubation period of 2-days was also observed by Lauder et al. (1971). In our 
study duration of the illness in rabbits was 13 days and it is in correlation with findings of 
other researchers as well who found that course of the disease lasted until the 22 or 27-DPI, 
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but in one cow, it lasted until 32-DPI in experimentally infected cow (Rehfeld et al., 2013), 
however, in cows with natural infections, it was from 15 to 30 days (Lobato et al., 2005). It 
should be noticed that heterogeneity of age, race, body condition, individual factors and herd 
possibly influence the time of healing. Recurrence of vesicles in the same teat point out that 
in the same outbreak infection could occur again, and for these events, milkers might act as a 
risk factor. Lesions evolved in experimental infection of rabbits followed the same pattern as 
explained in natural infections; erythema, formation of papules, vesicle stage of lesion 
followed by pustule development and then scabs, and at last, the stage of healing. Similar 
results were also observed by Lobato et al. (2005) and Trindade et al. (2006). It is observed 
that re-infection might occur under the conditions to which the animals are more prone to any 
infection like unhygienic conditions, immunosuppressed or immunocopromised animals. 
Generally, in re-infected cows with pox like agents, the lesions are mild and small as 
compared with lesions in cows inoculated ﬁrst time. The time between the infection for the 
first time and reinfection also affects the lesions severity. The animals reinoculated after 240 
days developed severe lesions compared with those observed in the animals re-inoculated 
after 70 days. This indicated that the antibodies observed in the re-infected cows after 70 
days may possibly promote local protection (Rehfeld et al., 2013). 
5.5.2 Histopathology of BPXV in rabbits 
In histological sections of cutaneous lesions from BPXV infected rabbits, there was 
marked hyperkeratosis in epidermis, mononuclear cell infiltration in connective tissue of 
dermis and vacuolar degeneration of keratinocytes. Most keratinocytes were characterized by 
ballooning degeneration with large intracytoplasmic, eosinophilic inclusion bodies. 
Manarolla et al., 2010 also described hyperkeratosis, vacuolar and ballooning degeneration, 
monocytic infiltration, and intracytoplasmic inclusion bodies in pox infection in cutaneous 
lesions. Singh and Singh (1967), and Chandra et al. (1987) findings of inclusion bodies are in 
agreement with our findings. They also stated that BPXV intracytoplasmic inclusion bodies 
were similar to those of CPXV, however, these showed different appearance from Guarnieri 
bodies of VACV that were small, plentiful, asymmetrical, granulated and eosinophilic. Other 
researchers also witnessed the presence of inclusion bodies (Essbauer and Meyer, 2007) and 
epithelial hyperplasia (Medina et al., 2004; Mohan and Fernandez, 2008) in pox infections in 
different species.  
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Countries in which BPX is endemic and there is difficulty in restriction of animal 
movement, disease control becomes complex. This problem is complexed in the absence of 
accurate prophylactic and diagnostic methods. Moreover, the contamination of mutton by 
BPXV is another issue for export. The economic concerns put a stop for adopting culling 
policy for buffaloes in Pakistan; however, prevention is the only choice. Without suitable 
immunopropylaxis, awareness and resources, the means of preventing the spread of BPXV 
infection is to make use of hygienic practices like segregation of the BPXV infected animals 
if some vaccine is not available. Delay in investigating and recognizing BPX eruption is a 
cause for concern and is attributed to lack of resources and poor awareness. 
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CHAPTER 6 
SUMMARY 
 A total of 96 herds were visited from different areas of Punjab densely populated with 
buffaloes for collection of data (n=975) along with blood samples (n=163) and scab samples 
(n=19) from clinical cases of this disease on different time intervals, comprising of two-
years.  
 Frequency analysis and 95% confidence limits showed that, significant effect (P < 
0.05) of following factors was observed in pox production: milker’s fever, milker’s skin 
lesions, presence of multiple species in the same herd, introduction of young buffaloes, total 
no. of animals, reluctance of animals during milking, milk yield and septic condition of 
animals with different percentages of pox positive animals. Non-significant effect (P > 0.05) 
of following factors was observed on disease production; multiple person milking, type of 
housing, age of the animal and type of herd. 
 Multivariate logistic regression analysis revealed that introduction of young 
buffaloes, total no. of animals, animals reluctant in milking, decreased milk production, 
septic condition in animals, milking from multiple persons, housing, area of sampling, age of 
animal and type of herd (dairy/mix) were backward eliminated factors. It was found that 
three factors were significantly associated (P < 0.05) with disease progression i.e. skin 
lesions in milkers, fever in milkers and presence of other animal species in the same herd. 
Log odd ratios showed that there were 6-times, 5-times and 3-times more chance of 
occurrence of pox disease in herds where milkers having skin lesions, milkers suffering from 
fever and animals other than buffaloes were also reared in the same herd, respectively. 
 Age hides the true association of factors with disease production that’s why after 
controlling the effect of age, analysis of multivariate logistic regression showed that a 
number of factors were significantly associated (P < 0.05) with disease production and those 
factors were: person suffering from fever, person exhibiting skin lesions, reluctance in 
milking, septic condition of animals, decreased milk production, other animals present, 
introduction of young buffaloes and total no. of animals. Log odd ratios showed that there 
was 11-times, 10-times, 5-times, 4-times, 4-times, 4-times, 2-times and 1-times more chance 
of occurrence of pox disease in herds where persons suffering from fever, persons having 
 
123 
 
 
skin lesions, animals reluctant in milking, septic condition in animals, decreased milk yield, 
rearing other animals alongwith buffaloes, addition of young buffaloes and total number of 
animals was more, respectively. Factors which were not significant (P > 0.05) in disease 
production were: milking from multiple persons, housing type, area of sampling and type of 
herd (dairy/mixed). 
 Pox lesions in BPXV infected animals were seen on teats during surveying and 
sampling for this research. Infection was self limiting and in few cases complicated with 
secondary bacterial contamination prolonging the duration of the illness, especially mastitis 
was observed in the affected animals. Different stages of BPX observed were; vesicle 
formation, deep seated ulcers, wet scabs with serous exudation, dry scab lesion, scab lesions 
with pits in the centers, wart like nodules, and blood oozing out indicating inflammatory 
lesions, dry scabs in a buffalo with history of permanent drop in production. Flies feeding the 
lesions diverted our attention of possible mechanical carrier for transmitting disease from one 
animal to another. Symptomatic treatment along with the administration of heavy doses of 
broad spectrum antibiotics to combat the infection and steroid injections to ease the animals, 
have been noticed exposing the animal to side effects of these drugs, definitely decreasing 
milk yield of the buffaloes. A number of human cases infected with BPXV have been 
observed during surveying and sampling, exhibiting different stages of pox lesions. Lesions 
in humans were mostly found on hands, face and around eyes. Different stages of lesions 
recorded were: vesiculation on hands, pustule stage alongwith pits in the centres on hand of 
mikers, pus filled lesions on eyes, high fever, regressed lesion with pits in the centres, and 
scar formation. During this research, lesions on eyes of kids having no history of direct 
contact with the buffaloes were also noticed; possible man to man transfer of BPXV. 
 Non-significant difference was observed on RBC count, Hb concentration, PCV and 
PLT in BPXV infected and healthy animals of age group 2-4 years, 5-7 years and 8-10 years 
age groups. Significant increase was observed on WBC count in BPXV infected buffaloes of 
all the groups and this increase was due to increase in number of lymphocytes. 
 Out of nineteen scab samples, fifteen samples were positive for BPX on the basis of 
PCR. Further, 78.94% scabs producing lesions were due to BPXV. 
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 Preventable fraction of Vero cell culture attenuated virus of 51st passaged, at 100 
TCID50 and at 1000 TCID50 is 100% and 66.67%, respectively. It can be used safely for 
vaccine preparation against BPXV in animals. 
 Lesions in skin of rabbits after infection with pathogenic type of BPXV, during its 
attenuation process, developed in the following manner; first there was congestion in spots 
after the entry of virus into epithelial cells, then due to proliferation of cells by the action of 
virus there was papule formation. After that, there was inflammatory hyperemia followed by 
serous exudation of corneum and vesiclulation stage. Afterword, due to entry of leukocytes 
into the vesicle, pustule stage developed. Then pustules dried forming a scab/crust which 
case off (desquamative stage). Fresh epithelium covered the lesion from the edges. The 
whole case comprised of 2 to 3 weeks. 
 In histological sections of lesions from BPXV infected animals, marked 
hyperkeratosis in epidermis, mononuclear cell infiltration in connective tissue of dermis and 
vacuolar degeneration of keratinocytes were observed. Ballooning degeneration with large 
intracytoplasmic, eosinophilic inclusion bodies were characteristic features in keratinocytes 
of BPXV infected rabbits. 
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